10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                 to                    

Commission file number: 0-12015

HEALTHCARE SERVICES GROUP, INC.

(Exact name of registrant as specified in its charter)

Pennsylvania	23-2018365
(State or other jurisdiction of  incorporation or organization)	(I.R.S. Employer Identification No.)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania

(Address of principal executive office)

19020

(Zip Code)

Registrant’s telephone number, including area code:

(215) 639-4274

Former name, former address and former fiscal year, if changed since last report:

Not Applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	HCSG	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  þ    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ☐  No  þ

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. Common Stock, $.01 par value: 74,539,000 shares outstanding as of October 20, 2021.

Healthcare Services Group, Inc.

Quarterly Report on Form 10-Q

For the Period Ended September 30, 2021

TABLE OF CONTENTS

		Page
PART I
Item 1.	Financial Statements (Unaudited)	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	39
Item 4.	Controls and Procedures	39
PART II
Item 1.	Legal Proceedings	41
Item 1A.	Risk Factors	41
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults Upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	42
SIGNATURES		43

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This report and documents incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry, primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the nine months ended September 30, 2021; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company’s expectations with respect to selling, general, and administrative expense; continued realization of tax benefits arising from our corporate reorganization and self-funded health insurance program; the impact of the concluded Securities and Exchange Commission investigation and ongoing related class action lawsuit; risks associated with the reorganization of our corporate structure; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2020 under “Government Regulation of Clients,” “Service Agreements and Collections,” and “Competition,” under Item IA. “Risk Factors” in such Form 10-K and under Item IA. “Risk Factors” in this Form 10-Q.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

Healthcare Services Group, Inc.

Consolidated Balance Sheets

(in thousands, except per share amounts)

(Unaudited)

	September 30, 2021		December 31, 2020
ASSETS:
Current assets:
Cash and cash equivalents	$	79,582	$	139,330
Marketable securities, at fair value	125,583		125,012
Accounts and notes receivable, less allowance for doubtful accounts of $61,879 and $59,906 as of September 30, 2021 and December 31, 2020, respectively	289,725		255,474
Inventories and supplies	26,714		31,586
Prepaid expenses and other assets	44,460		21,001
Total current assets	566,064		572,403
Property and equipment, net	27,817		26,561
Goodwill	65,545		51,084
Other intangible assets, less accumulated amortization of $26,715 and $23,466 as of September 30, 2021 and December 31, 2020, respectively	17,039		18,187
Notes receivable — long–term portion, less allowance for doubtful accounts of $6,135 and $7,895 as of September 30, 2021 and December 31, 2020, respectively	30,651		34,417
Deferred compensation funding, at fair value	50,711		46,825
Deferred income taxes	35,776		35,554
Total assets	$	793,603	$	785,031
LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable	$	50,493	$	52,239
Accrued payroll and related taxes	42,354		70,614
Other accrued expenses	36,843		17,797
Accrued insurance claims	24,164		21,610
Total current liabilities	153,854		162,260
Accrued insurance claims — long-term portion	63,135		60,818
Deferred compensation liability	50,747		46,827
Accrued payroll and related taxes - noncurrent	23,302		23,302
Lease liability — long-term portion	11,798		11,363
Other long-term liabilities	10,562		—
Commitments and contingencies (Note 14)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 100,000 shares authorized; 75,997 and 75,798 shares issued, and 74,565 and 74,485 shares outstanding as of September 30, 2021 and December 31, 2020, respectively	760		758
Additional paid-in capital	291,899		282,206
Retained earnings	197,550		200,893
Accumulated other comprehensive income, net of taxes	3,981		5,563
Common stock in treasury, at cost, 1,432 and 1,313 shares as of September 30, 2021 and December 31, 2020, respectively	(13,985)		(8,959)
Total stockholders’ equity	480,205		480,461
Total liabilities and stockholders’ equity	$	793,603	$	785,031

See accompanying notes to consolidated financial statements.

1

Healthcare Services Group, Inc.

Consolidated Statements of Comprehensive Income

(in thousands, except per share amounts)

(Unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenues	$	415,590	$	435,947	$	1,221,512	$	1,337,126
Operating costs and expenses:
Costs of services provided	364,822		365,443		1,037,852		1,140,116
Selling, general and administrative expense	38,780		37,337		128,818		108,819
Other income (expense):
Investment and other income, net	462		4,279		6,311		7,197
Interest expense	(329)		(314)		(1,017)		(1,062)
Income before income taxes	12,121		37,132		60,136		94,326
Income tax provision	2,581		9,488		16,378		23,391
Net income	$	9,540	$	27,644	$	43,758	$	70,935
Per share data:
Basic earnings per common share	$	0.13	$	0.37	$	0.58	$	0.95
Diluted earnings per common share	$	0.13	$	0.37	$	0.58	$	0.95
Weighted average number of common shares outstanding:
Basic	74,943		74,700		74,983		74,684
Diluted	75,076		74,777		75,170		74,768
Comprehensive income:
Net income	$	9,540	$	27,644	$	43,758	$	70,935
Other comprehensive income:
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(1,014)		873		(1,582)		1,996
Total comprehensive income	$	8,526	$	28,517	$	42,176	$	72,931

See accompanying notes to consolidated financial statements.

2

Healthcare Services Group, Inc.

Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

	Nine Months Ended September 30,
	2021		2020
Cash flows from operating activities:
Net income	$	43,758	$	70,935
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,961		10,752
Bad debt provision	10,790		6,756
Deferred income tax expense (benefit)	198		(8,247)
Share-based compensation expense	6,968		5,917
Amortization of premium on marketable securities	1,740		1,409
Unrealized gain on deferred compensation fund investments	(3,958)		(4,210)
Loss on sale of assets	1,157		—
Changes in operating assets and liabilities:
Accounts and notes receivable	(41,275)		22,440
Inventories and supplies	4,872		3,825
Prepaid expenses and other assets	(23,459)		(3,588)
Deferred compensation funding	72		488
Accounts payable and other accrued expenses	10,694		(9,104)
Accrued payroll, accrued and withheld payroll taxes	(26,085)		14,356
Income taxes payable	—		17,420
Accrued insurance claims	4,871		8,450
Deferred compensation liability	4,427		3,950
Net cash provided by operating activities	5,731		141,549
Cash flows from investing activities:
Disposals of fixed assets	201		475
Additions to property and equipment	(4,202)		(3,074)
Purchases of marketable securities	(16,683)		(8,242)
Sales of marketable securities	12,368		5,979
Cash paid for acquisition	(6,000)		—
Net cash used in investing activities	(14,316)		(4,862)
Cash flows from financing activities:
Dividends paid	(46,672)		(45,383)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan	69		69
Proceeds from the exercise of stock options	2,238		1,893
Purchases of treasury stock	(5,397)		—
Repayments of short-term borrowings	—		(10,000)
Payments of statutory withholding on net issuance of restricted stock units	(1,401)		(675)
Net cash used in financing activities	(51,163)		(54,096)
Net change in cash and cash equivalents	(59,748)		82,591
Cash and cash equivalents at beginning of the period	139,330		27,329
Cash and cash equivalents at end of the period	$	79,582	$	109,920
Supplemental disclosure of non-cash investing activities
Accrued variable consideration from acquisition of a business	$	10,562	$	—

See accompanying notes to consolidated financial statements.

3

Healthcare Services Group, Inc.

Consolidated Statements of Stockholders’ Equity

(in thousands)

(Unaudited)

	For the nine months ended September 30, 2021
	Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income, net of taxes		Retained Earnings		Treasury Stock		Stockholders’ Equity
	Shares	Amount
Balance, December 31, 2020	75,798	$	758	$	282,206	$	5,563	$	200,893	$	(8,959)	$	480,461
Comprehensive income:
Net income for the period	—	—		—		—		24,653		—		24,653
Unrealized loss on available-for-sale marketable securities, net of taxes	—	—		—		(1,271)		—		—		(1,271)
Comprehensive income for the period												$	23,382
Exercise of stock options and other share-based compensation, net of shares tendered for payment	156	2		1,473		—		—		—		1,475
Payment of statutory withholding on issuance of restricted stock units	—	—		(1,501)		—				—		(1,501)
Share-based compensation expense	—	—		2,104		—		—		—		2,104
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		545		—		—		(36)		509
Shares issued pursuant to Employee Stock Plan	—	—		1,554		—		—		498		2,052
Dividends paid and accrued, $0.21 per share	—	—		—		—		(15,526)		—		(15,526)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		18		—		—		5		23
Other	4	—		123		—		—		—		123
Balance, March 31, 2021	75,958	$	760	$	286,522	$	4,292	$	210,020	$	(8,492)	$	493,102
Comprehensive income:
Net income for the period	—	—		—		—		9,565		—		9,565
Unrealized gain on available-for-sale marketable securities, net of taxes	—	—		—		703		—		—		703
Comprehensive income for the period												$	10,268
Exercise of stock options and other share-based compensation, net of shares tendered for payment	11	—		380		—		—		—		380
Share-based compensation expense	—	—		2,159		—		—		—		2,159
Purchases of treasury stock	—	—		—		—		—		(1,835)		(1,835)
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		60		—		—		(61)		(1)
Dividends paid and accrued, $0.21 per share	—	—		—		—		(15,792)		—		(15,792)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		17		—		—		6		23
Balance, June 30, 2021	75,969	$	760	$	289,138	$	4,995	$	203,793	$	(10,382)	$	488,304
Comprehensive income:
Net income for the period	—	—		—		—		9,540		—		9,540
Unrealized loss on available-for-sale marketable securities, net of taxes	—	—		—		(1,014)		—		—		(1,014)
Comprehensive income for the period												$	8,526
Exercise of stock options and other share-based compensation, net of shares tendered for payment	28	—		383		—		—		—		383
Payment of statutory withholding on issuance of restricted stock units	—	—		100		—		—		—		100
Share-based compensation expense	—	—		2,214		—		—		—		2,214
Purchases of treasury stock	—	—		—		—		—		(3,562)		(3,562)
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		50		—		—		(50)		—
Dividends paid and accrued, $0.21 per share	—	—		—		—		(15,783)		—		(15,783)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		14		—		—		9		23
Balance, September 30, 2021	75,997	$	760	$	291,899	$	3,981	$	197,550	$	(13,985)	$	480,205

See accompanying notes to consolidated financial statements.

4

	For the nine months ended September 30, 2020
	Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income, net of taxes		Retained Earnings		Treasury Stock		Stockholders’ Equity
	Shares	Amount
Balance, December 31, 2019	75,557	$	756	$	270,614	$	2,919	$	195,455	$	(9,439)	$	460,305
Adjustment to adopt credit-loss guidance1	—	—		—		—		(32,099)		—		(32,099)
Balance, January 1, 2020	75,557	$	756	$	270,614	$	2,919	$	163,356	$	(9,439)	$	428,206
Comprehensive income:
Net income for the period	—	—		—		—		20,190		—		20,190
Unrealized loss on available-for-sale marketable securities, net of taxes	—	—		—		(533)		—		—		(533)
Comprehensive income for the period												$	19,657
Exercise of stock options and other share-based compensation, net of shares tendered for payment	162	1		1,723		—		—		—		1,724
Payment of statutory withholding on issuance of restricted stock and restricted stock units	—	—		(661)		—		—		—		(661)
Share-based compensation expense	—	—		1,822		—		—		—		1,822
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		417		—		—		111		528
Shares issued pursuant to Employee Stock Plan	—	—		1,329		—		—		506		1,835
Dividends paid and accrued, $0.20 per share	—	—		—		—		(15,142)		—		(15,142)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		16		—		—		7		23
Other	6	—		187		—		—		—		187
Balance, March 31, 2020	75,725	$	757	$	275,447	$	2,386	$	168,404	$	(8,815)	$	438,179
Comprehensive income:
Net income for the period	—	—		—		—		23,101		—		23,101
Unrealized gain on available-for-sale marketable securities, net of taxes	—	—		—		1,656		—		—		1,656
Comprehensive income for the period												$	24,757
Exercise of stock options and other stock-based compensation, net of shares tendered for payment	7	—		138		—		—		—		138
Share-based compensation expense	—	—		1,830		—		—		—		1,830
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		51		—		—		(53)		(2)
Dividends paid and accrued, $0.20 per share	—	—		—		—		(15,237)		—		(15,237)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		16		—		—		6		22
Balance, June 30, 2020	75,732	$	757	$	277,482	$	4,042	$	176,268	$	(8,862)	$	449,687
Comprehensive income:
Net income for the period	—	—		—		—		27,644		—		27,644
Unrealized gain on available-for-sale marketable securities, net of taxes	—	—		—		873		—		—		873
Comprehensive income for the period	—	—		—		—		—		—		$	28,517
Exercise of stock options and other share-based compensation, net of shares tendered for payment	2	—		31		—		—		—		31
Payment of statutory withholding on issuance of restricted stock and restricted stock units	—	—		(14)		—		—		—		(14)
Share-based compensation expense	—	—		1,840		—		—		—		1,840
Treasury shares issued for Deferred Compensation Plan funding and redemptions	—	—		53		—		—		(54)		(1)
Dividends paid and accrued, $0.20 per share	—	—		—		—		(15,334)		—		(15,334)
Shares issued pursuant to Dividend Reinvestment Plan	—	—		16		—		—		8		24
Balance, September 30, 2020	75,734	$	757	$	279,408	$	4,915	$	188,578	$	(8,908)	$	464,750

1.See Note 4—Allowance for Doubtful Accounts regarding the new credit-loss guidance.

See accompanying notes to consolidated financial statements.

5

Healthcare Services Group, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

Note 1—Description of Business and Significant Accounting Policies

Nature of Operations

Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs.

The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility.

Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.

Unaudited Interim Financial Data

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2020 has been derived from the audited financial statements for the year ended December 31, 2020. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for any future period.

Use of Estimates in Financial Statements

In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

6

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.

Accounts and Notes Receivable

Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided.

Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss.

Refer to Note 3—Accounts and Notes Receivable herein for further information.

Allowance for Doubtful Accounts

The guidance under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”) became effective and was adopted by the Company prospectively as of January 1, 2020. In adopting ASC 326, the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables for its reporting of quarterly and annual financial results with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate the lifetime expected credit losses on such instruments and to record an allowance to offset the receivables. ASC 326 requires the recognition of credit losses that are expected based on existing accounts and notes receivable as compared to the incurred loss approach. Accordingly, credit losses under ASC 326 generally are recognized earlier in the life cycle of a receivable than under the Company’s previous incurred loss model. Modeling must be prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Under the previous incurred loss impairment model, credit losses were recognized when Management determined that it was more likely than not that a loss had been incurred and such loss was estimable.

Refer to Note 4—Allowance for Doubtful Accounts herein for further information.

Inventories and Supplies

Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.

7

Revenue Recognition

The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services. Refer to Note 2—Revenue herein for further information.

Leases

The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, in accordance with FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”). A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of September 30, 2021 and December 31, 2020, the Company was only the lessee of operating lease arrangements.

Refer to Note 7—Leases herein for further information.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not.

Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.

Earnings per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock units.

Share-Based Compensation

The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.

Identifiable Intangible Assets and Goodwill

Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value.

No impairment loss was recognized on the Company's intangible assets or goodwill during the nine months ended September 30, 2021 or 2020.

8

Concentrations of Credit Risk

The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At September 30, 2021 and December 31, 2020, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets.

The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.

Note 2—Revenue

The Company presents its consolidated revenues disaggregated by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 12—Segment Information herein as well as the information below regarding the Company’s reportable segments.

Housekeeping

Housekeeping accounted for $621.3 million and $675.4 million of the Company’s consolidated revenues for the nine months ended September 30, 2021 and 2020, respectively, which represented approximately 50.9% and 50.5% of the Company’s revenues in each respective period. The Housekeeping services include managing customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality-control procedures including continuous training and employee evaluation.

Dietary

Dietary services accounted for $600.2 million and $661.8 million of the Company’s consolidated revenues for the nine months ended September 30, 2021 and 2020, respectively, which represented approximately 49.1% and 49.5% of the Company’s revenues in each respective period. Dietary services consist of managing customers’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to customers. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.

9

Revenue Recognition

The Company’s revenues are derived from contracts with customers. The Company accounts for revenue from contracts with customers in accordance with ASC 606, and as such, the Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company is entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material.

The Company performs services and provides goods in accordance with its customers' contracts. Such contracts typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice, after an initial period of 60 to 120 days. A performance obligation is the unit of account under ASC 606 and is defined as a promise in a contract to transfer a distinct good or service to the customer. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services that are substantially the same and that have the same pattern of transfer to the customer. The Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the customers’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was $0.4 million and $0.1 million as of September 30, 2021 and December 31, 2020, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2020 were subsequently recognized as revenue during the nine months ended September 30, 2021.

The transaction price is the amount of consideration to which the Company is entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when the Company determines that there will not be a significant reversal in the amount of revenue recognized. The Company’s contracts generally do not contain significant financing components, as payment terms are less than one year.

The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represent a single performance obligation satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. As of September 30, 2021 and December 31, 2020, the value of the contract liabilities associated with customer prepayments was less than $0.1 million and $2.3 million, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2020 were subsequently recognized as revenue during the nine months ended September 30, 2021.

Transaction Price Allocated to Remaining Performance Obligations

The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

At September 30, 2021, the Company had $298.9 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 41.3% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consist of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.

10

Note 3—Accounts and Notes Receivable

The Company’s accounts and notes receivable balances consisted of the following as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Short-term
Accounts and notes receivable	$	351,604	$	315,380
Allowance for doubtful accounts	(61,879)		(59,906)
Total net short-term accounts and notes receivable	$	289,725	$	255,474
Long-term
Notes receivable	$	36,786	$	42,312
Allowance for doubtful accounts	(6,135)		(7,895)
Total net long-term notes receivable	$	30,651	$	34,417
Total net accounts and notes receivable	$	320,376	$	289,891

The Company makes credit decisions on a case-by-case basis after reviewing a number of qualitative and quantitative factors related to the specific customer as well as current industry variables that may impact that customer. There are a variety of factors that impact a customer’s ability to pay in accordance with the Company’s contracts. These factors include, but are not limited to, fluctuating census numbers, litigation costs and the customer’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the customer’s cash flows and its ability to make timely payments. However, the customer’s obligation to pay the Company in accordance with the contracts are not contingent upon the customer’s cash flow. Notwithstanding the Company’s efforts to minimize its credit risk exposure, the aforementioned factors, as well as other factors that impact customer cash flows or ability to make timely payments, could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition.

Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition, modification or termination of customer relationships. The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes to enhance the collectability of amounts due, by instituting definitive repayment plans and providing a means by which to further evidence the amounts owed. In addition, the Company may amend contracts from full service to management-only arrangements, or adjust contractual payment terms, to accommodate customers who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk.

Note 4—Allowance for Doubtful Accounts

In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition.

The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a triggering event such as bankruptcy. At the end of each period, the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable.

11

The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established, recognizing the environment of the long-term care industry, and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. Interest income from notes receivable for both the three months ended September 30, 2021 and 2020 was $0.3 million, respectively. Interest income from notes receivable for the nine months ended September 30, 2021 and 2020 was $1.0 million and $1.3 million, respectively.

As part of the Company’s adoption of ASC 326, there are additional disclosures required to be made on a class of financing receivable basis. The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the current nine month period ended September 30, 2021.

	Notes Receivable
	Amortized Cost Basis by Origination Year
	2021		2020		2019		2018		2017		Prior		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	11,414	$	8,181	$	2,060	$	18,980	$	21,289	$	1,560	$	63,484
Elevated risk notes receivable	$	—	$	—	$	617	$	—	$	723	$	1,374	$	2,714
Current-period gross write-offs	$	—	$	—	$	—	$	315	$	2,493	$	—	$	2,808
Current-period recoveries	—		—		(1)		—		—		(37)		(38)
Current-period net write-offs	$	—	$	—	$	(1)	$	315	$	2,493	$	(37)	$	2,770

The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of September 30, 2021:

	Age Analysis of Past-Due Notes Receivable as of September 30, 2021
	0-90 Days		91 - 180 Days		Greater than 181 Days		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	5,709	$	877	$	5,589	$	12,175
Elevated risk notes receivable	—		—		2,714		2,714
	$	5,709	$	877	$	8,303	$	14,889

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2021		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	50,243	$	(427)	$	4,230	$	54,046
Notes Receivable
Standard notes receivable	$	12,534	$	—	$	(149)	$	12,385
Elevated risk notes receivable	1,583		—		—		1,583
Total notes receivable	$	14,117	$	—	$	(149)	$	13,968
Total accounts and notes receivable	$	64,360	$	(427)	$	4,081	$	68,014

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2021, the Company collected an immaterial amount of accounts receivables and notes receivables which had previously been written-off as uncollectible.

12

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2020		Write-Offs1		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	66,299	$	(2,475)	$	967	$	64,791
Notes Receivable
Standard notes receivable	$	11,869	$	(253)	$	(132)	$	11,484
Elevated risk notes receivable	5,818		—		—		5,818
Total notes receivable	$	17,687	$	(253)	$	(132)	$	17,302
Total accounts and notes receivable	$	83,986	$	(2,728)	$	835	$	82,093

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2020, the Company collected $0.1 million of accounts receivables which had previously been written-off as uncollectible.

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the nine months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2020		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	51,052	$	(7,807)	$	10,801	$	54,046
Notes receivable
Standard notes receivable	$	13,258	$	(9)	$	(864)	$	12,385
Elevated risk notes receivable	3,491		(2,761)		853		1,583
Total notes receivable	$	16,749	$	(2,770)	$	(11)	$	13,968
Total accounts and notes receivable	$	67,801	$	(10,577)	$	10,790	$	68,014

1.Write-offs are shown net of recoveries. During the nine months ended September 30, 2021, the Company collected $0.1 million of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2019		Cumulative effect of ASC 326 adoption1		Write-Offs2		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	39,903	$	36,709	$	(16,871)	$	5,050	$	64,791
Notes receivable
Standard notes receivable	$	6,667	$	5,236	$	(1,974)	$	1,555	$	11,484
Elevated risk notes receivable	5,823		291		(447)		151		5,818
Total notes receivable	$	12,490	$	5,527	$	(2,421)	$	1,706	$	17,302
Total accounts and notes receivable	$	52,393	$	42,236	$	(19,292)	$	6,756	$	82,093

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.

2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables which had previously been written-off as uncollectible.

13

Note 5—Changes in Accumulated Other Comprehensive Income by Component

The Company's accumulated other comprehensive income consists of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following table provides a summary of the changes in accumulated other comprehensive income for the nine months ended September 30, 2021 and 2020:

	Unrealized Gains and Losses on Available-for-Sale Securities1
	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Accumulated other comprehensive income — beginning balance	$	5,563	$	2,919
Other comprehensive (loss) income before reclassifications	(1,421)		1,925
(Gains) losses reclassified from other comprehensive income2	(161)		71
Net current period other comprehensive (loss) income3	(1,582)		1,996
Accumulated other comprehensive income — ending balance	$	3,981	$	4,915

1.All amounts are net of tax

2.Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the nine months ended September 30, 2021, the Company recorded $0.2 million of realized gains from the sale of available-for-sale securities. For the nine months ended September 30, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information.

3.For the nine months ended September 30, 2021, the changes in other comprehensive income were net of a tax benefit of $0.4 million. For the nine months ended September 30, 2020, the changes in other comprehensive income were net of a tax expense of $0.5 million.

	Amounts Reclassified from Accumulated Other Comprehensive Income
	2021		2020
	(in thousands)
Three Months Ended September 30,
Losses from the sale of available-for-sale securities	$	(7)	$	(7)
Tax benefit	5		2
Net loss reclassified from accumulated other comprehensive income	$	(2)	$	(5)
Nine Months Ended September 30,
Gains (losses) from the sale of available-for-sale securities	$	221	$	(94)
Tax (expense) benefit	(60)		23
Net gain (loss) reclassified from accumulated other comprehensive income	$	161	$	(71)

14

Note 6—Property and Equipment

Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred.

The following table sets forth the amounts of property and equipment by each class of depreciable asset as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Housekeeping and dietary equipment	$	13,145	$	13,862
Computer hardware and software	5,402		6,015
Operating lease — right-of-use assets	32,032		26,074
Other1	1,601		1,581
Total property and equipment, at cost	52,180		47,532
Less accumulated depreciation	24,363		20,971
Total property and equipment, net	$	27,817	$	26,561

1.Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases.

Depreciation expense for both the three months ended September 30, 2021 and 2020 was $2.5 million. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $7.7 million and $7.6 million, respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2021, $1.6 million and $4.7 million related to the depreciation of the Company’s operating lease - right-of-use assets (“ROU Assets”), respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2020, $1.4 million and $4.2 million related to the depreciation of the Company’s operating lease - right-of-use assets (“ROU Assets”), respectively.

Note 7—Leases

The Company recognizes ROU Assets and lease liabilities (“Lease Liabilities”) for automobiles, office buildings, IT equipment, and small storage units for the temporary storage of operational equipment. The Company’s leases have remaining lease terms ranging from less than 1 year to 8 years, and have extension options ranging from 1 year to 5 years. Most leases include the option to terminate the lease within 1 year.

Upon adopting ASC 842, the Company made accounting policy elections using practical expedients offered under the guidance to combine lease and non-lease components within leasing arrangements and to recognize the payments associated with short-term leases in earnings on a straight-line basis over the lease term, with the cost associated with variable lease payments recognized when incurred. These accounting policy elections impact the value of the Company’s ROU Assets and Lease Liabilities. The value of the Company’s ROU Assets is determined as the non-depreciated fair value of its leasing arrangements and is recorded to Property and Equipment, net on the Company’s Consolidated Balance Sheets. The value of the Company’s Lease Liabilities is the present value of fixed lease payments not yet paid, discounted using either the rate implicit in the lease contract if that rate can be determined, or the Company’s incremental borrowing rate (“IBR”) and is recorded in Other accrued expenses and Lease liability — long-term portion on the Company’s Consolidated Balance Sheets. The Company’s IBR is determined as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

Any future lease payments that are not fixed based on the terms of the lease contract, or fluctuate based on a factor other than an index or rate, are considered variable lease payments and are not included in the value of the Company’s ROU Assets or Lease Liabilities. The Company's variable lease payments are mostly incurred from automobile leases and relate to miscellaneous transportation costs including repair costs, insurance, and terminal rental adjustments payments due at lease settlement. Such rental adjustment payments can result in a reduction to the Company's total variable lease payments.

15

Components of lease expense required by ASC 842 are presented below for the three and nine months ended September 30, 2021 and 2020.

	Three Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	1,629	$	1,404
Short-term lease cost	122		135
Variable lease cost	73		188
Total lease cost	$	1,824	$	1,727

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	4,547	$	4,153
Short-term lease cost	558		388
Variable lease cost	(458)		450
Total lease cost	$	4,647	$	4,991

Supplemental information required by ASC 842 is presented below for the nine months ended September 30, 2021 and 2020.

	Nine Months Ended September 30,
	2021			2020
	(dollar amounts in thousands)
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4,902		$	2,793
Weighted-average remaining lease term — operating leases	4.8 years			5.1 years
Weighted-average discount rate — operating leases	4.2		%	4.9		%

During the three and nine months ended September 30, 2021, the Company’s ROU Assets and Lease Liabilities were reduced by $0.3 million and $0.6 million, respectively, due to lease cancellations. During the three and nine months ended September 30, 2020, the Company's ROU Assets and Lease Liabilities were reduced by $0.1 million and $0.3 million, respectively, due to lease cancellations.

16

The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of September 30, 2021:

Period/Year	Operating Leases
	(in thousands)
October 1 to December 31, 2021	$	1,683
2022	6,131
2023	4,354
2024	2,225
2025	1,311
2026	1,337
Thereafter	2,867
Total minimum lease payments	$	19,908
Less: imputed lease discount	$	1,700
Present value of lease liabilities	$	18,208

Note 8—Other Intangible Assets

The Company’s other intangible assets consist of customer relationships, patents, non-compete agreements, and trademarks which were obtained through acquisitions and are recorded at their fair values at the date of acquisition. Intangible assets with determinable lives are amortized on a straight-line basis over their estimated useful lives. The weighted average amortization period of the Company's intangible assets was 9.9 years.

The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2021, the following five fiscal years and thereafter:

Period/Year	Total Amortization Expense
	(in thousands)
October 1 to December 31, 2021	$	1,105
2022	$	4,416
2023	$	3,420
2024	$	2,286
2025	$	2,286
2026	$	2,270
Thereafter	$	1,256

Amortization expense for the three and nine months ended September 30, 2021 was $1.1 million and $3.3 million, respectively. Amortization expense for the three and nine months ended September 30, 2020 was $1.0 million and $3.1 million, respectively.

Note 9—Fair Value Measurements

The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities and inventories) are recorded at cost in the Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations.

17

The Company’s marketable securities primarily consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in other comprehensive income (net of tax) within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the three and nine months ended September 30, 2021, the Company recorded unrealized losses, net of taxes of $1.0 million and $1.6 million on marketable securities, respectively. For the three and nine months ended September 30, 2020, the Company recorded unrealized gains, net of taxes of $0.9 million and $2.0 million on marketable securities, respectively.

For the three months ended September 30, 2021 and 2020, the Company received total proceeds, less the amount of interest received, of $0.3 million and $0.2 million, respectively, from sales of available-for-sale municipal bonds. For both the three months ended September 30, 2021 and 2020, these sales resulted in realized losses of less than $0.1 million. For the nine months ended September 30, 2021 and 2020, the Company received total proceeds, less the amount of interest received, of $12.4 million and $6.0 million, respectively, from sales of available-for-sale municipal bonds. For the nine months ended September 30, 2021 and 2020, these sales resulted in realized gains of $0.2 million and realized losses of $0.1 million, respectively, which were recorded in “Other income – Investment and other income, net” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period.

The investments under the funded deferred compensation plan are accounted for as trading securities and unrealized gains or losses are included in earnings. The fair value of these investments are determined based on quoted market prices (Level 1). For the three months ended September 30, 2021 and 2020, the Company recognized unrealized losses of $0.1 million and unrealized gains of $3.2 million, respectively, related to equity securities still held at the respective reporting dates. For the nine months ended September 30, 2021 and 2020, the Company's recognized unrealized gains of $4.0 million and $4.2 million, respectively, related to equity securities still held at the respective reporting dates.

The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of September 30, 2021 and December 31, 2020:

	As of September 30, 2021
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,583	$	125,583	$	—	$	125,583	$	—
Deferred compensation fund
Money Market1	$	2,934	$	2,934	$	—	$	2,934	$	—
Balanced and Lifestyle	11,922		11,922		11,922		—		—
Large Cap Growth	18,833		18,833		18,833		—		—
Small Cap Growth	6,010		6,010		6,010		—		—
Fixed Income	4,882		4,882		4,882		—		—
International	2,328		2,328		2,328		—		—
Mid Cap Growth	3,801		3,801		3,801		—		—
Deferred compensation fund	$	50,711	$	50,711	$	47,777	$	2,934	$	—

18

	As of December 31, 2020
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,012	$	125,012	$	—	$	125,012	$	—
Deferred compensation fund
Money Market1	$	3,006	$	3,006	$	—	$	3,006	$	—
Balanced and Lifestyle	10,815		10,815		10,815		—		—
Large Cap Growth	17,223		17,223		17,223		—		—
Small Cap Growth	5,337		5,337		5,337		—		—
Fixed Income	4,850		4,850		4,850		—		—
International	2,250		2,250		2,250		—		—
Mid Cap Growth	3,344		3,344		3,344		—		—
Deferred compensation fund	$	46,825	$	46,825	$	43,819	$	3,006	$	—

1.The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		Other-than-temporary Impairments
	(in thousands)
September 30, 2021
Type of security:
Municipal bonds — available-for-sale	$	120,543	$	5,316	$	(276)	$	125,583	$	—
Total debt securities	$	120,543	$	5,316	$	(276)	$	125,583	$	—
December 31, 2020
Type of security:
Municipal bonds — available-for-sale	$	117,970	$	7,043	$	(1)	$	125,012	$	—
Total debt securities	$	117,970	$	7,043	$	(1)	$	125,012	$	—

The following table summarizes the contractual maturities of debt securities held at September 30, 2021 and December 31, 2020, which are classified as marketable securities in the Consolidated Balance Sheets:

	Municipal Bonds — Available-for-Sale
Contractual maturity:	September 30, 2021		December 31, 2020
	(in thousands)
Maturing in one year or less	$	6,207	$	2,927
Maturing in second year through fifth year	32,788		26,324
Maturing in sixth year through tenth year	52,902		55,366
Maturing after ten years	33,686		40,395
Total debt securities	$	125,583	$	125,012

19

Note 10—Shared-Based Compensation

The components of the Company’s shared-based compensation expense for the nine months ended September 30, 2021 and 2020 are as follows:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Stock options	$	1,381	$	1,594
Restricted stock units and deferred stock units	4,797		3,898
Performance stock units	299		—
Employee Stock Purchase Plan	491		425
Total pre-tax share-based compensation expense charged against income1	$	6,968	$	5,917

1.Share-based compensation expense is recorded in cost of services and selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.

At September 30, 2021, the unrecognized compensation cost related to unvested stock options and awards was $20.0 million. The weighted average period over which these awards will vest is approximately 2.9 years.

2020 Omnibus Incentive Plan

On May 26, 2020, the Company adopted the 2020 Omnibus Incentive Plan (the “2020 Plan”) after approval by the Company's Shareholders at the Annual Meeting of Shareholders. The 2020 Plan provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, performance stock units, restricted stock units and other stock awards. The 2020 Plan seeks to encourage profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company's operating objectives.

As of September 30, 2021, there were 4.9 million shares of common stock reserved for issuance under the 2020 Plan, of which, 2.0 million are available for future grant. The amount of shares available for issuance under the 2020 Plan will increase when outstanding awards under the Company's Second Amended and Restated 2012 Equity Incentive Plan (the “2012 Plan”) are subsequently forfeited, terminated, lapsed, or satisfied thereunder in cash or property other than shares. No stock award will have a term in excess of 10 years. The Nominating, Compensation and Stock Option Committee (the “NCSO”) of the Board of Directors is responsible for determining the terms of the grants in accordance with the 2020 Plan.

Stock Options

A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2020 and changes during the nine months ended September 30, 2021 are as follows:

	Stock Options Outstanding
	Number of Shares	Weighted Average Exercise Price
	(in thousands)
December 31, 2020	2,098	$	33.35
Granted	207	$	28.45
Exercised	(98)	$	22.93
Forfeited	(1)	$	39.38
Expired	(10)	$	33.64
September 30, 2021	2,196	$	33.35

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2021 and 2020 was $7.01 and $4.65 per common share, respectively. The total intrinsic value of stock options exercised during the nine months ended September 30, 2021 and 2020 was $0.6 million and $0.9 million, respectively.

20

The fair value of stock option awards granted in 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021		2020
Risk-free interest rate	0.6	%	1.8	%
Weighted average expected life	6.6 years		6.6 years
Expected volatility	34.7	%	26.6	%
Dividend yield	2.9	%	3.2	%

The following table summarizes other information about the stock options at September 30, 2021:

	September 30, 2021
	(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value	$	900
Weighted average remaining contractual life	5.1 years
Exercisable:
Number of options	1,551
Weighted average exercise price	$	33.32
Aggregate intrinsic value	$	800
Weighted average remaining contractual life	4.0 years

Restricted Stock Units

The fair value of outstanding restricted stock units was determined based on the market price of the shares on the date of grant. During the nine months ended September 30, 2021, the Company granted 0.3 million restricted stock units to its employees with a weighted average grant date fair value of $28.53 per unit. During the nine months ended September 30, 2020, the Company granted 0.3 million restricted stock units with a weighted average grant date fair value of $24.43 per unit.

During the nine months ended September 30, 2021 and 2020, the Company did not grant any restricted stock.

A summary of the outstanding restricted stock units as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Restricted Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	561	$	33.31
Granted	262	$	28.53
Vested	(147)	$	35.48
Forfeited	(12)	$	29.88
September 30, 2021	664	$	31.01

21

Performance Stock Units

On January 4, 2021, the NCSO granted 35,000 Performance Stock Units (“PSUs”) to the Company's executive officers. Such PSUs are contingent upon the achievement of certain total shareholder return (“TSR”) targets as compared to the TSR of the S&P 400 MidCap Index and the participant's continued employment with the Company for the three year period ending December 31, 2023, the date at which such awards vest. The unrecognized share-based compensation cost of the TSR-based PSU awards at September 30, 2021 is $0.9 million and is expected to be recognized over a weighted-average period of 2.4 years.

A summary of the outstanding PSUs as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Performance Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	—	$	—
Granted	35	$	34.52
Vested	—	$	—
Forfeited	—	$	—
September 30, 2021	35	$	34.52

Deferred Stock Units

On June 4, 2021, the NCSO granted 10,000 Deferred Stock Units (“DSUs”) to the Company's non-employee directors. Each DSU award vests in one year. Once vested, the recipient shall be entitled to receive a lump sum payment of a number of shares equal to the total number of DSUs issued to such recipient upon the first to occur of (i) the five year anniversary of the date of grant, (ii) the recipient's death, disability or separation of service from the Board, or (iii) a change of control (as defined by the 2020 Plan). The unrecognized share-based compensation cost of the DSU awards at September 30, 2021 is $0.2 million and is expected to be recognized over a weighted-average period of 0.7 years.

Employee Stock Purchase Plan

The Company’s Employee Stock Purchase Plan (“ESPP”) is currently available through 2026 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day.

Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 2.1 million shares available for future grant at September 30, 2021.

The expense associated with the options granted under the ESPP during the nine months ended September 30, 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021	2020
Risk-free interest rate	0.1%	1.6%
Weighted average expected life (years)	1.0	1.0
Expected volatility	61.7%	42.0%
Dividend yield	2.9%	3.3%

22

Deferred Compensation Plan

The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP allows participants to defer a portion of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a match of a portion of their deferral in the form of the Company’s common stock based on the then-current market value. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.3 million shares available for future grant at September 30, 2021. At the time of issuance, such shares are accounted for at cost as treasury stock.

The following table summarizes information about the SERP during the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
SERP expense 1	$	458	$	444
Unrealized gain recorded in SERP liability account	$	3,990	$	3,973

1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.

23

Note 11—Income Taxes

The Company’s annual effective tax rate is impacted by the tax effects of option exercises, vested awards, and the payment pertaining to the settlement with the Securities and Exchange Commission (“SEC”) to resolve its investigation, which are all treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on the Company’s income tax provision through the nine months ended September 30, 2021 for such discrete items was approximately $2.2 million.

Differences between the effective tax rate and the applicable U.S. federal statutory rate arise primarily from the effect of state and local income taxes, share-based compensation and tax credits available to the Company. The actual 2021 effective tax rate will likely vary from the estimate depending on the actual operating income earned with availability of tax credits and the exercise of stock options and vesting of share-based awards.

The Company accounts for income taxes using the asset and liability method, which results in recognizing income tax expense based on the amount of income taxes payable or refundable for the current year. Additionally, the Company regularly evaluates the tax positions taken or expected to be taken resulting from financial statement recognition of certain items. Based on the evaluation, there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The evaluation was performed for the tax years ended December 31, 2017 through 2020 (with regard to U.S. federal income tax returns) and December 31, 2016 through 2020 (with regard to various state and local income tax returns), the tax years which remain subject to examination by major tax jurisdictions as of September 30, 2021.

The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense.

Note 12—Segment Information

The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve a similar customer base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete contracts, specific to each reportable segment.

24

The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Revenues
Housekeeping	$	203,379	$	223,423	$	621,278	$	675,366
Dietary	212,211		212,524		600,234		661,760
Total	$	415,590	$	435,947	$	1,221,512	$	1,337,126
Income before income taxes
Housekeeping	$	17,237	$	24,784	$	68,025	$	73,983
Dietary	7,259		19,630		41,075		52,627
Corporate and eliminations1	(12,375)		(7,282)		(48,964)		(32,284)
Total	$	12,121	$	37,132	$	60,136	$	94,326

1.Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.

25

Note 13—Earnings Per Common Share

Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options, restricted stock units, and performance stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Numerator for basic and diluted earnings per share:
Net income	$	9,540	$	27,644	$	43,758	$	70,935
Denominator:
Weighted average number of common shares outstanding - basic	74,943		74,700		74,983		74,684
Effect of dilutive securities 1	133		77		187		84
Weighted average number of common shares outstanding - diluted	75,076		74,777		75,170		74,768
Basic earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95
Diluted earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95

1.Certain outstanding equity awards are anti-dilutive and therefore excluded from the calculation of the weighted average number of diluted common shares outstanding.

Anti-dilutive outstanding equity awards under share-based compensation plans were as follows:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
	(in thousands)
Anti-dilutive	2,184	2,244	1,788	2,145

Note 14—Other Contingencies

Line of Credit

At September 30, 2021, the Company had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a float rate, based on the Company’s leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). As of September 30, 2021 and December 31, 2020, there were no borrowings under the line of credit. The line of credit requires the Company to satisfy two financial covenants, with which the Company is in compliance as of September 30, 2021. The line of credit expires on December 21, 2023.

At September 30, 2021, the Company also had outstanding $64.9 million in irrevocable standby letters of credit, which relate to payment obligations under the Company’s insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $64.9 million to $410.1 million at September 30, 2021. The letters of credit expire on January 4, 2022.

Tax Jurisdictions and Matters

The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities.

26

The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters.

Legal Proceedings

The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. In accordance with FASB ASC 450 – Contingencies (“ASC 450”), as the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In accordance with ASC 450, the Company does not accrue for contingent losses that, in its judgment, are considered to be reasonably possible but not probable. In the event the Company determines that adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides disclosure regarding the matter, including a range of possible loss when the exposure is estimable, as required by ASC 450.

As previously disclosed, the Securities and Exchange Commission (the “SEC”) conducted an investigation into the Company’s earnings per share (“EPS”) calculation practices. Following receipt of a letter from the SEC in November 2017 regarding its inquiry into those practices and a subpoena in March 2018, the Company authorized King & Spalding to conduct an internal investigation, under the direction of the Company’s Audit Committee, into matters related to the SEC subpoena. This investigation was completed in March 2019, and the Company continued to cooperate with the SEC’s investigation and document requests after that time. The Company, its former Chief Financial Officer (now current Chief Administrative Officer), and its Controller reached a settlement with the SEC, which was approved by the SEC commissioners and publicly announced on August 24, 2021. The Company and the individuals neither admitted nor denied the findings in the Commission's order, which stated, among other things, that during certain quarters between 2014 and 2015, the Company failed to timely record the financial impact of certain loss contingencies and maintain accurate books, records and sufficient internal account controls. Under the terms of the settlement, the Company paid a $6.0 million civil monetary penalty during the third quarter of 2021.

On March 22, 2019, a putative shareholder class action lawsuit was filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania, seeking unspecified monetary damages and other relief on behalf of the plaintiff class. The initial complaint, which was filed by a plaintiff purportedly on behalf of all purchasers of the Company’s securities between April 11, 2017 and March 4, 2019 (the “Class Period”), alleges violations of the federal securities laws in connection with the matters related to the Company’s EPS calculation practices. On September 17, 2019, the complaint was amended to, among other things, extend the Class Period to cover the period between April 8, 2014 and March 4, 2019, and to name additional individuals affiliated with the Company as defendants.

On March 17, 2021, the parties reached an agreement in principle to settle the action on a class-wide basis. On June 30, 2021, the plaintiff filed an unopposed motion for an order preliminarily approving a proposed class action settlement, preliminarily certifying the settlement class, and approving notice to the settlement class. On September 15, 2021, the Court entered an order preliminarily approving the $16.8 million settlement and providing for notice to settlement class members. Our insurance carriers have agreed to pay the entirety of the settlement amount upon court approval of the settlement. As of March 31, 2021, the associated contingency was included within the “Other accrued expenses” and “Prepaid expenses and other assets” captions on the Company's Consolidated Balance Sheet. Refer to Note 15—Subsequent Events herein for further information.

The Company continues to vigorously defend against all active litigation claims asserted. Any of the foregoing matters could result in substantial costs to the Company, divert management’s attention and resources, and adversely affect the Company’s business condition or harm its reputation, regardless of their merit or outcome. In addition, the uncertainty of the pending lawsuits or potential filing of additional lawsuits could lead to more volatility and a reduction in the Company’s stock price.

27

Government Regulations

The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care many of whom have been significantly impacted by COVID-19. For those customers who were impacted, the pandemic has resulted in increased operating costs, reductions in new resident admitants, and reduced census. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or additional changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. There have been several enacted and proposed federal and state relief measures as a result of COVID-19 which should provide support for these customers during this pandemic, however, the full benefit of any such programs would not be realized until these programs are fully implemented, government agencies issue applicable regulations or guidance and such relief is provided.

Note 15—Subsequent Events

On October 15, 2021 the Company’s directors’ and officers’ liability insurance carriers paid a $16.8 million settlement to resolve a putative shareholder class action lawsuit originally filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania on March 22, 2019.

28

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

Results of Operations

The following discussion is intended to provide the reader with information that will be helpful in understanding our financial statements, including the changes in certain key items when comparing financial statements period to period. We also intend to provide the primary factors that accounted for those changes, as well as a summary of how certain accounting principles affect our financial statements. In addition, we are providing information about the financial results of our two operating segments to further assist in understanding how these segments and their results affect our consolidated results of operations. This discussion should be read in conjunction with our financial statements as of September 30, 2021 and December 31, 2020 and the notes accompanying those financial statements.

COVID-19 Considerations

The Company’s priorities during the COVID-19 pandemic are protecting the health and safety of our employees; maximizing the impact of our main services in helping customers with the housekeeping and dietary services needs of their facilities, and deploying the talents of our employees and our resources to help the communities we serve meet and overcome the current challenges. In the quarter ended September 30, 2021, the COVID-19 pandemic did not have a material net impact on our consolidated operating results. Revenues for the quarter ended September 30, 2021 included $5.2 million of COVID-19 supplemental billings, primarily related to employee pay premiums passed through to customers, which were offset by temporary decreases in recurring billings as a result of census-driven cost reductions in staffing and purchasing. In the future, the pandemic may cause reduced demand for our services if, for example, the pandemic results in a recessionary economic environment to the long-term care and skilled nursing industries in which we serve; however since the services that we offer are essential to our customers, and although there can be no assurance, we believe that over the long term, there will continue to be strong demand for our services. The full impact that COVID-19 will have on our future revenues is not known at this time.

Our ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees, with particular measures in place for those working in our customer facilities. For the quarter ended September 30, 2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with nursing departments to do our part in the infection prevention and control continuum and remain flexible in responding to our customer-partners. However, the continued uncertainty resulting from the pandemic and the effect of the vaccine could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.

Through September 30, 2021, we continue to generate operating cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.

For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2020 (the “Form 10-K”).

Overview

We provide management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of healthcare facilities, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. We believe we are the largest provider of housekeeping and laundry management services to the long-term care industry in the United States, rendering such services to approximately 3,000 facilities throughout the continental United States as of September 30, 2021.

We provide services primarily pursuant to full service agreements with our customers. Under such agreements, we are responsible for the day-to-day management of the employees located at our customers’ facilities, as well as for the provision of certain supplies. We also provide services on the basis of management-only agreements for a limited number of customers. Under a management-only agreement, we provide management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. Our agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

29

We are organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing our customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, we typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.

Dietary consists of managing our customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. We also offer clinical consulting services to our dietary customers, which may be provided as a stand-alone service, or bundled with other dietary department services. Upon beginning service with a customer facility, we typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.

At September 30, 2021, Housekeeping services were provided at essentially all of our approximately 3,000 customer facilities, generating approximately 50.9% or $621.3 million of our total revenues for the nine months ended September 30, 2021. Dietary services were provided to over 1,500 customer facilities at September 30, 2021 and contributed approximately 49.1% or $600.2 million of our total revenues for the nine months ended September 30, 2021.

30

Three Months Ended September 30, 2021 and 2020

The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the three months ended September 30, 2021 and 2020. The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.

	Three Months Ended September 30,
	2021		2020		% Change
	(in thousands)
Revenues
Housekeeping	$	203,379	$	223,423	(9.0)	%
Dietary	212,211		212,524		(0.1)	%
Consolidated	$	415,590	$	435,947	(4.7)	%
Costs of services provided
Housekeeping	$	186,142	$	198,639	(6.3)	%
Dietary	204,952		192,894		6.3	%
Corporate and eliminations	(26,272)		(26,090)		0.7	%
Consolidated	$	364,822	$	365,443	(0.2)	%
Selling, general and administrative expense
Corporate and eliminations	$	38,780	$	37,337	3.9	%
Investment and other income, net
Corporate and eliminations	$	462	$	4,279	(89.2)	%
Interest expense
Corporate and eliminations	$	(329)	$	(314)	4.8	%
Income (loss) before income taxes
Housekeeping	$	17,237	$	24,784	(30.5)	%
Dietary	7,259		19,630		(63.0)	%
Corporate and eliminations	(12,375)		(7,282)		(69.9)	%
Consolidated	$	12,121	$	37,132	(67.4)	%

Housekeeping and Dietary revenues represented approximately 48.9% and 51.1% of consolidated revenues for the three months ended September 30, 2021, respectively.

31

The following table sets forth the ratio of certain items to consolidated revenues:

	Three Months Ended September 30,
	2021		2020
Revenues	100.0	%	100.0	%
Operating costs and expenses:
Costs of services provided	87.8	%	83.8	%
Selling, general and administrative expense	9.3	%	8.6	%
Other income (expense):
Investment and other income, net	0.1	%	1.0	%
Interest expense	(0.1)	%	(0.1)	%
Income before income taxes	2.9	%	8.5	%
Income tax	0.6	%	2.2	%
Net income	2.3	%	6.3	%

Revenues

Consolidated

Consolidated revenues decreased 4.7% to $415.6 million for the three months ended September 30, 2021 compared to $435.9 million for the corresponding period in 2020, as a result of the factors discussed below under Reportable Segments.

Reportable Segments

Housekeeping and Dietary revenues decreased 9.0% and 0.1%, respectively, during the three months ended September 30, 2021 compared to the corresponding period in 2020, primarily driven by decreases in recurring billings as a result of census-driven reductions in staffing and purchasing, a decrease in the number of facilities serviced and an agreement with a customer to modified pricing and payment terms, offset by $0.5 million of COVID-19 supplemental billings recognized during the three months ended September 30, 2021, primarily related to employee pay premiums passed through to customers. The full impact that COVID-19 will have on our future revenues is not yet known at this time.

Costs of Services Provided

Consolidated

Consolidated costs of services provided decreased by 0.2% to $364.8 million for the three months ended September 30, 2021 compared to $365.4 million for the three months ended September 30, 2020. During the three months ended September 30, 2021, costs of services related to COVID-19 were primarily billed back to our customers. Any future increases to both labor and supplies expense as a result of COVID-19 are possible, however we anticipate, although there can be no assurance, that we will be reimbursed from our customers for most COVID-19 related costs which are outside the scope of services or supplies which we are contractually obligated. The terms in our service agreements support this anticipation and the expectation of our customers' eligibility for additional reimbursement under enacted and proposed government regulations.

The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:

	Three Months Ended September 30,
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue	2021	2020	Change
Bad debt provision	1.0%	0.2%	0.8%
Self-insurance costs	2.9%	2.7%	0.2%

The increase in the bad debt provision was impacted by the current aging of our accounts receivables as of the quarter ended September 30, 2021.

32

Reportable Segments

Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, increased to 91.5% for the three months ended September 30, 2021 from 88.9% in the corresponding period in 2020. Costs of services provided for Dietary, as a percentage of Dietary revenues, increased to 96.6% for the three months ended September 30, 2021 from 90.8% in the corresponding period in 2020.

The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:

	Three Months Ended September 30,
Costs of Services Provided - Key Indicators as a % of Segment Revenue	2021	2020	Change
Housekeeping labor and other labor-related costs	81.9%	80.5%	1.4%
Housekeeping supplies	6.7%	6.7%	—%
Dietary labor and other labor-related costs	64.8%	63.1%	1.7%
Dietary supplies	28.8%	25.8%	3.0%

The increase in the cost of housekeeping and dining labor as a percentage of the respective revenues was driven by increased wage rates and premium pay to stabilize labor shortages while the increase in the cost of dietary supplies was driven by continued inflation during the quarter ended September 30, 2021.

Consolidated Selling, General and Administrative Expense 

Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Losses on the plan investments during the three months ended September 30, 2021 decreased our total selling, general and administrative expense, while gains on plan investments during the corresponding period in 2020 increased our total selling, general and administrative expense. There is a possibility for additional increased selling, general and administrative expense related to the pandemic but such costs at this time are not expected to be material.

Excluding the change in the deferred compensation plan described above, consolidated selling, general and administrative expense increased $4.9 million or 14.3% for the three months ended September 30, 2021 compared to the corresponding period in 2020. The increase was driven by increased payroll costs and increased travel and entertainment costs incurred during the search for new business.

The table below summarizes the changes in these components of selling, general and administrative expense:

	Three Months Ended September 30,
	2021		2020		$ Change		% Change
	(dollar amounts in thousands)
Selling, general and administrative expense excluding change in deferred compensation liability	$	38,996	$	34,127	$	4,869	14.3	%
(Loss) gain on deferred compensation plan investments	(216)		3,210		(3,426)		106.7	%
Selling, general and administrative expense	$	38,780	$	37,337	$	1,443	3.9	%

Consolidated Investment and Other Income, net

Investment and other income decreased 89.2% to $0.5 million for the three months ended September 30, 2021 compared to the corresponding 2020 period, primarily due to market fluctuations in the value of our trading security investments representing the funding for our deferred compensation plan.

33

Consolidated Interest Expense

Consolidated interest expense increased 4.8% to $0.3 million for the three months ended September 30, 2021.

Consolidated Income Taxes

During the three months ended September 30, 2021, the Company recognized a provision for income taxes of $2.6 million, or 21.3% effective tax rate, versus $9.5 million, or 25.6% effective tax rate, for the same period in 2020. The actual annual effective tax rate will be impacted by the tax effects of option exercises, vested awards, and the payment pertaining to the settlement with the SEC to resolve its investigation, which are all treated as discrete items in the reporting period in which they occur, and therefore are not considered in the calculation of the estimated annual effective tax rate. The impact on our income tax provision for the three months ended September 30, 2021 for such discrete items was $0.7 million.

The Company’s estimate for the 2021 effective tax rate has not been adjusted for any impact related to COVID-19 as the impact on the Company's effective tax rate at this time is not expected to be material.

Nine Months Ended September 30, 2021 and 2020

The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the nine months ended September 30, 2021 and 2020. The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.

	Nine Months Ended September 30,
	2021		2020		% Change
	(in thousands)
Revenues
Housekeeping	$	621,278	$	675,366	(8.0)	%
Dietary	600,234		661,760		(9.3)	%
Consolidated	$	1,221,512	$	1,337,126	(8.6)	%
Costs of services provided
Housekeeping	$	553,253	$	601,383	(8.0)	%
Dietary	559,159		609,133		(8.2)	%
Corporate and eliminations	(74,560)		(70,400)		5.9	%
Consolidated	$	1,037,852	$	1,140,116	(9.0)	%
Selling, general and administrative expense
Corporate and eliminations	$	128,818	$	108,819	18.4	%
Investment and other income, net
Corporate and eliminations	$	6,311	$	7,197	(12.3)	%
Interest expense
Corporate and eliminations	$	(1,017)	$	(1,062)	(4.2)	%
Income (loss) before income taxes
Housekeeping	$	68,025	$	73,983	(8.1)	%
Dietary	41,075		52,627		(22.0)	%
Corporate and eliminations	(48,964)		(32,284)		51.7	%
Consolidated	$	60,136	$	94,326	(36.2)	%

34

Housekeeping and Dietary revenues represented approximately 50.9% and 49.1% of consolidated revenues for the nine months ended September 30, 2021, respectively.

The following table sets forth the ratio of certain items to consolidated revenues:

	Nine Months Ended September 30,
	2021		2020
Revenues	100.0	%	100.0	%
Operating costs and expenses:
Costs of services provided	85.0	%	85.3	%
Selling, general and administrative expense	10.5	%	8.1	%
Other income (expense):
Investment and other income, net	0.5	%	0.5	%
Interest expense	(0.1)	%	(0.1)	%
Income before income taxes	4.9	%	7.0	%
Income tax	1.3	%	1.7	%
Net income	3.6	%	5.3	%

Revenues

Consolidated

Consolidated revenues decreased 8.6% to $1.2 billion for the nine months ended September 30, 2021 compared to $1.3 billion for the corresponding period in 2020 as a result of the factors discussed below under Reportable Segments.

Reportable Segments

Housekeeping and Dietary revenues decreased 8.0% and 9.3%, respectively, during the nine months ended September 30, 2021 compared to the corresponding period in 2020, primarily driven by decreases in recurring billings as a result of census-driven reductions in staffing and purchasing, a decrease in number of facilities serviced and an agreement with a customer to modified pricing and payment terms, offset by $5.2 million of COVID-19 supplemental billings recognized during the nine months ended September 30, 2021, primarily related to employee pay premiums passed through to customers. The full impact that COVID-19 will have on our future revenues is not yet known at this time.

Costs of services provided

Consolidated

Consolidated costs of services provided decreased in line with revenues of 9.0% to $1.0 billion for the nine months ended September 30, 2021 compared to $1.1 billion for the nine months ended September 30, 2020.

The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:

	Nine Months Ended September 30,
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue	2021	2020	Change
Bad debt provision	0.9%	0.5%	0.4%
Self-insurance costs	2.8%	2.7%	0.1%

Self-insurance costs have remained steady and the increase in the bad debt provision was impacted by the current aging of our accounts receivables as of September 30, 2021.

Reportable Segments

Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, increased to 89.1% for the nine months ended September 30, 2021 from 89.0% in the corresponding period in 2020. Costs of services provided for Dietary, as a percentage of Dietary revenues, increased to 93.2% for the nine months ended September 30, 2021 from 92.0% in the corresponding period in 2020.

35

The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:

	Nine Months Ended September 30,
Costs of Services Provided - Key Indicators as a % of Segment Revenue	2021	2020	Change
Housekeeping labor and other labor-related costs	80.1%	80.2%	(0.1)%
Housekeeping supplies	6.4%	7.0%	(0.6)%
Dietary labor and other labor-related costs	63.8%	63.5%	0.3%
Dietary supplies	26.8%	26.5%	0.3%

Variations within these key indicators relate to the provision of services at facilities served and changes in the mix of customers for whom we provide supplies or do not provide supplies. Management focuses on building efficiencies and managing labor and other costs at the facility level, as well as managing supply chain costs, for new and existing facilities. The increase in dietary supplies spend as a percentage of dining revenues was driven by continued inflation and the mix of business where we provide all dining department supplies.

Consolidated Selling, General and Administrative Expense

Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Gains on the plan investments during the nine months ended September 30, 2021 and 2020 increased our total selling, general and administrative expense for these periods. There is a possibility for additional increased selling, general and administrative expense related to the pandemic but such costs at this time are not expected to be material.

Excluding the change in the deferred compensation plan described above, consolidated selling, general and administrative expense increased $20.0 million or 19.1% for the nine months ended September 30, 2021 compared to the corresponding period in 2020. The increase was primarily a result of increased payroll costs, increased travel and entertainment costs incurred during the search for new business and increased legal and professional fees incurred, including $6.0 million related to the settlement of the SEC inquiry regarding the Company's earnings per share calculation practices and $3.0 million related to a negotiated settlement of California labor and employment matters.

The table below summarizes the changes in these components of selling, general and administrative expense:

	Nine Months Ended September 30,
	2021		2020		$ Change		% Change
	(dollar amounts in thousands)
Selling, general and administrative expense excluding change in deferred compensation liability	$	124,827	$	104,846	$	19,981	19.1	%
(Loss) gain on deferred compensation plan investments	3,991		3,973		18		(0.5)	%
Selling, general and administrative expense	$	128,818	$	108,819	$	19,999	18.4	%

Consolidated Investment and Interest Income, net

Investment and other income decreased 12.3% to $6.3 million for the nine months ended September 30, 2021 compared to the corresponding 2020 period, primarily due to market fluctuations in the value of our trading security investments representing the funding for our deferred compensation plan.

Consolidated Interest Expense

Consolidated interest expense decreased 4.2% to $1.0 million for the nine months ended September 30, 2021 compared to the corresponding 2020 period due to less interquarter borrowings.

36

Consolidated Income Taxes

During the nine months ended September 30, 2021 and 2020, the Company recognized a provision for income taxes of $16.4 million, or 27.2% and $13.9 million or 24.8%, respectively. The actual annual effective tax rate will be impacted by the tax effects of option exercises, vested awards, and the payment pertaining to the settlement with the SEC to resolve its investigation, which are all treated as discrete items in the reporting period in which they occur, and therefore are not considered in the calculation of the estimated annual effective tax rate. The impact on our income tax provision for the nine months ended September 30, 2021 for such discrete items was approximately $2.2 million.

The Company’s estimate for the 2021 effective tax rate has not been adjusted for any impacts related to COVID-19 as the impact at this time is not expected to be material.

Liquidity and Capital Resources

Cash generated through operations is our primary source of liquidity. At September 30, 2021, we had cash, cash equivalents and marketable securities of $205.2 million and working capital of $412.2 million, compared to December 31, 2020 cash, cash equivalents and marketable securities of $264.3 million and working capital of $410.1 million. Our current ratio was 3.7 to 1 at September 30, 2021 versus 3.5 to 1 at December 31, 2020. Marketable securities represent fixed income investments that are highly liquid and can be readily purchased or sold through established markets. Such securities are held by our captive insurance company to satisfy capital requirements of the state regulator related to captive insurance companies. Through September 30, 2021, the pandemic has not negatively impacted the Company’s liquidity position.

For the nine months ended September 30, 2021 and 2020, our cash flows were as follows:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Net cash provided by operating activities	$	5,731	$	141,549
Net cash used in investing activities	$	(14,316)	$	(4,862)
Net cash used in financing activities	$	(51,163)	$	(54,096)

Operating Activities

Our primary sources of cash from operating activities are the revenues generated from our Housekeeping and Dietary services. Our primary uses of cash from operating activities are the funding of our payroll and other personnel-related costs, as well as the costs of supplies used in providing our services. For the nine months ended September 30, 2020 cash flow from operations included a $32.3 million increase which related to the deferral of payroll taxes under the Coronavirus Aid, Relief, and Economic Security Act. Such deferral, along with the timing of cash receipts and cash payments, offset by the decrease in net income are the primary drivers of the period-over-period changes in net cash provided by operating activities

We have not changed our expectations on future cash flows from operating activities due to COVID-19. We anticipate that several of our customers may experience changes in their cash flows however we will continue to pursue collections in accordance with our service agreements.

Investing Activities

Our principal uses of cash for investing activities are the purchases of marketable securities and capital expenditures such as those for housekeeping and food service equipment, computer software and equipment, and furniture and fixtures (see “Capital Expenditures” below for additional information). Such uses of cash are partially offset by proceeds from sales of marketable securities. On April 26, 2021, we acquired a business for $16.5 million, inclusive of $6.0 million in cash and $10.5 million in accrued variable consideration. We have recognized the transaction as a business combination; however, we are still working to finalize the allocation of the purchase price.

Our investments in marketable securities are primarily comprised of tax-exempt municipal bonds and are intended to achieve our goal of preserving principal, maintaining adequate liquidity and maximizing returns subject to our investment guidelines. Our investment policy limits investment to certain types of instruments issued by institutions primarily with investment-grade ratings and places restrictions on concentration by type and issuer.

37

Financing Activities

The primary use of cash for financing activities is the payment of dividends. We have paid regular quarterly cash dividends since the second quarter of 2003. During 2021, we paid a regular quarterly cash dividend to shareholders totaling $46.7 million as follows:

	Quarter Ended
	September 30, 2021		June 30, 2021		March 31, 2021
Cash dividend paid per common share	$	0.20875	$	0.20750	$	0.20625
Total cash dividends paid	$	15,640	$	15,560	$	15,472
Record date	August 20, 2021		May 21, 2021		February 26, 2021
Payment date	September 24, 2021		June 25, 2021		March 26, 2021

The dividends paid to shareholders during the nine months ended September 30, 2021 were funded by cash generated from operations. Our Board of Directors reviews our dividend policy on a quarterly basis. Although there can be no assurance that we will continue to pay dividends or regarding the amount of future dividend payments, we expect to continue to pay a regular quarterly cash dividend. In connection with the establishment of our dividend policy, we adopted a Dividend Reinvestment Plan in 2003.

We remain authorized to repurchase 1.4 million shares of our common stock pursuant to previous Board of Directors’ authorization. The Company entered into a 10b5-1 plan (the “Plan”). The Plan was adopted under the safe harbor provided by Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in order to assist the Company in implementing its share repurchase plans. Pursuant to the Company's share repurchase program and as authorized by the Board of Directors on March 12, 2021, we have purchased 0.2 million shares of the Company's common stock during the nine months ended September 30, 2021 for a total cost of $5.4 million inclusive of transaction costs.

Line of Credit

At September 30, 2021, we had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a floating rate, based on our leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). At September 30, 2021, there were no borrowings under the line of credit.

The line of credit requires us to satisfy two financial covenants. The covenants and their respective status at September 30, 2021 were as follows:

Covenant Descriptions and Requirements	As of September 30, 2021
Funded debt 1 to EBITDA 2 ratio: less than 3.50 to 1.00	0.26
EBITDA to Interest Expense ratio: not less than 3.00 to 1.00	85.51

1.All indebtedness for borrowed money including, but not limited to, capitalized lease obligations, reimbursement obligations in respect of letters of credit and guarantees of any such indebtedness.

2.Net income plus interest expense, income tax expense, depreciation, amortization, stock compensation expense and extraordinary non-recurring losses/gains.

As noted above, we were in compliance with our financial covenants at September 30, 2021 and we expect to remain in compliance. The line of credit expires on December 21, 2023. We believe that our existing capacity under the line of credit provides adequate liquidity.

LIBOR is expected to be discontinued after 2021. Our line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. However, there can be no assurance as to whether such replacement or alternative rate will be more or less favorable than LIBOR. We intend to monitor the developments with respect to the potential phasing out of LIBOR after 2021 and will work with our lenders to ensure any transition away from LIBOR will have minimal impact on our financial condition. We however can provide no assurances regarding the impact of the discontinuation of LIBOR on the interest rate that we would be required to pay or on our financial condition.

At September 30, 2021, we also had outstanding $64.9 million in irrevocable standby letters of credit, which relate to payment obligations under our insurance programs.

38

Capital Expenditures

The level of capital expenditures is generally dependent on the number of new customers obtained. Such capital expenditures primarily consist of housekeeping and food service equipment purchases, laundry and linen equipment installations, computer hardware and software, and furniture and fixtures. Although we have no specific material commitments for capital expenditures through the end of calendar year 2021, we estimate that for 2021 we will have capital expenditures of approximately $5.0 million to $7.0 million, of which we have made $4.2 million through September 30, 2021. We believe that our cash from operations, existing cash and cash equivalents balance and credit line will be adequate for the foreseeable future to satisfy the needs of our operations and to fund our anticipated growth. However, should these sources not be sufficient, we would seek to obtain necessary capital from such sources as long-term debt or equity financing.

Material Off-Balance Sheet Arrangements

We have no material off-balance sheet arrangements, other than our irrevocable standby letter of credit previously discussed.

Critical Accounting Policies and Estimates

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report on Form 10-K (the “Form 10-K”) for the period ended December 31, 2020. As described in such notes, we recognize revenue in the period in which the performance obligation is satisfied. Refer to our Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Form 10-K.

In preparing our financial statements, management is required to make estimates and assumptions that, among other things, affect the reported amounts of assets, liabilities, revenue and expenses. These estimates and assumptions are most significant when they involve levels of subjectivity and judgment necessary to account for highly uncertain matters or matters susceptible to change, and where they can have a material impact on our financial condition and operating performance. If actual results were to differ materially from the estimates made, the reported results could be materially affected.

Critical accounting estimates and the related assumptions are evaluated periodically as conditions warrant, and changes to such estimates are recorded as new information or changed conditions require.

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

At September 30, 2021, we had $205.2 million in cash, cash equivalents and marketable securities. The fair value of all of our cash equivalents and marketable securities are determined based on “Level 1” or “Level 2” inputs, which are based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. We place our cash investments in instruments that meet credit quality standards, as specified in our investment policy guidelines.

Investments in both fixed-rate and floating-rate investments carry a degree of interest rate risk. The market value of fixed rate securities may be adversely impacted by an increase in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectations due to changes in interest rates or if there is a decline in the fair value of our investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are intended to ensure that information required to be disclosed in our reports under the Exchange Act, such as this Form 10-Q, is reported in accordance with Securities and Exchange Commission rules. Disclosure controls are also intended to ensure that such information is accumulated and communicated to Management, including the Principal Executive Officer (President and Chief Executive Officer) and Principal Financial Officer (Principal Accounting Officer), as appropriate, to allow timely decisions regarding required disclosure.

Based on their evaluation as of September 30, 2021, pursuant to Exchange Act Rule 13a-15(b), our Management, including our Principal Executive Officer and Principal Financial Officer, believe our disclosure controls and procedures (as defined in Exchange Act 13a-15(e)) are effective.

39

Changes in Internal Controls over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting that occurred during the nine months ended September 30, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal control over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.

Certifications

Certifications of the Principal Executive Officer and Principal Financial and Accounting Officer regarding, among other items, disclosure controls and procedures are included as exhibits to this Form 10-Q.

40

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

In the normal course of business, the Company is involved in various administrative and legal proceedings, including labor and employment, contracts, personal injury, and insurance matters.

As previously disclosed, the SEC conducted an investigation into our EPS calculation practices. Following receipt of a letter from the SEC in November 2017 regarding its inquiry into those practices and a subpoena in March 2018, we authorized King & Spalding to conduct an internal investigation, under the direction of the Company’s Audit Committee, into matters related to the SEC subpoena. This investigation was completed in March 2019, and we continued to cooperate with the SEC’s investigation and document requests after that time. The Company, our former CFO (now current Chief Administrative Officer), and our Controller reached a settlement with the SEC, which was approved by the SEC commissioners and publicly announced on August 24, 2021. The Company and the individuals neither admitted nor denied the findings in the Commission's order, which stated, among other things, that during certain quarters between 2014 and 2015, the Company failed to timely record the financial impact of certain loss contingencies and maintain accurate books, records and sufficient internal account controls. Under the terms of the settlement, we paid a $6.0 million civil monetary penalty during the third quarter of 2021.

On March 22, 2019, a putative shareholder class action lawsuit was filed against the Company and our Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania, seeking unspecified monetary damages and other relief on behalf of the plaintiff class. The initial complaint, which was filed by a plaintiff purportedly on behalf of all purchasers of our securities between April 11, 2017 and March 4, 2019 (the “Class Period”), alleges violations of the federal securities laws in connection with the matters related to our EPS calculation practices. On September 17, 2019, the complaint was amended to, among other things, extend the Class Period to cover the period between April 8, 2014 and March 4, 2019, and to name additional individuals affiliated with the Company as defendants.

On March 17, 2021, the parties reached an agreement in principle to settle the action on a class-wide basis. On June 30, 2021, the plaintiff filed an unopposed motion for an order preliminarily approving a proposed class action settlement, preliminarily certifying the settlement class, and approving notice to the settlement class. On September 15, 2021, the Court entered an order preliminarily approving the settlement and providing for notice to settlement class members. The $16.8 million settlement was funded by the Company's directors' and officers' liability insurance carriers and paid on or about October 15, 2021. The Court has scheduled a final approval hearing for January 10, 2022.

The Company continues to vigorously defend against all active litigation claims asserted. Any of the foregoing matters could result in substantial costs to the Company, divert management’s attention and resources, and adversely affect the Company’s business condition or harm its reputation, regardless of their merit or outcome. In addition, the uncertainty of the pending lawsuits or potential filing of additional lawsuits could lead to more volatility and a reduction in the Company’s stock price.

In light of the uncertainties involved in such proceedings, the ultimate outcome of a particular matter could become material to the Company’s results of operations for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of the Company’s operating income for that period.

Item 1A. Risk Factors

There have been no other material changes in the risk factors set forth in Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

41

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On March 12, 2021, the Company's Board of Directors authorized and the Company entered into a 10b5-1 plan (the “Plan”). The Plan was adopted under the safe harbor provided by Rule 10b5-1 and Rule 10b-18 of the Exchange Act, in order to assist the Company in implementing its share repurchase plans.

Shares repurchased pursuant to the Plan during the nine months ended September 30, 2021, were as follows.

Nine Months Ended September 30, 2021	Total number of shares of common stock repurchased	Average price paid per share of common stock1		Aggregate purchase price of common stock repurchases		Number of remaining shares authorized for repurchase
				(in thousands)
Second quarter	60,500	$	30.41	$	1,835	1,585
July	31,500	$	30.31	$	929	1,553
August	45,750	26.07		1,193		1,507
September	55,500	25.97		1,439		1,452
Third quarter	132,750	$	27.45	$	3,562	1,452
Year-to-date	193,250	$	28.93	$	5,397	1,452

1.Excludes commissions cost.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

On July 20, 2021, Healthcare Services Group, Inc. adopted Amendment No. 4 to the Healthcare Services Group, Inc. Employee Stock Purchase Plan (the “ESPP”), originally effective as of January 1, 2000, and as amended effective January 1, 2004, April 12, 2011, and August 1, 2016. The Amendment No. 4 extends the ESPP for an additional five years through 2026.

Item 6. Exhibits

The following exhibits are filed as part of this Report:

Exhibit Number	Description
4.1*	Amendment No. 4 to the Healthcare Services Group, Inc. Employee Stock Purchase Plan, dated as of July 20, 2021
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
32.1	Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act
101	The following financial information from the Company’s Form 10-Q for the quarterly period ended September 30, 2021 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Cash Flows, (iv) Consolidated Statement of Stockholders’ Equity, and (v) Notes to Consolidated Financial Statements
104	Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)

* Indicates a management plan or compensatory plan or arrangement.

42

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant had duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HEALTHCARE SERVICES GROUP, INC.
Date:	October 22, 2021	/s/ Theodore Wahl
		Theodore Wahl
		President & Chief Executive Officer
		(Principal Executive Officer)
Date:	October 22, 2021	/s/ Andrew M. Brophy
		Andrew M. Brophy
		Principal Accounting Officer
		(Principal Financial and Accounting Officer)

43

EX-31.1

Exhibit 31.1

Certification of the Principal Executive Officer

Pursuant to Rules 13a-14(a) and 15d-14(a)

Under the Securities Exchange Act, as Amended

I, Theodore Wahl, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Services Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 22, 2021	/s/ Theodore Wahl
		Theodore Wahl
		President & Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of the Principal Financial Officer

Pursuant to Rules 13a-14(a) and 15d-14(a)

Under the Securities Exchange Act, as Amended

I, Andrew M. Brophy, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Healthcare Services Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	October 22, 2021	/s/ Andrew M. Brophy
		Andrew M. Brophy
		Principal Accounting Officer
		(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CertificationPursuant to

18 U.S.C. Section 1350,

As AdoptedPursuant to

Section 906 ofthe Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Healthcare Services Group, Inc. (the "Company") for the quarter ended September 30, 2021 as filed with the Securities and Exchange commission on the date hereof (the "Form 10-Q"), Theodore Wahl, the Chief Executive Officer of the Company, and Andrew M. Brophy, the Principal Accounting Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d), of the Securities Exchange Act of 1934, as amended; and

(2) That information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Theodore Wahl	/s/ Andrew M. Brophy
Theodore Wahl	Andrew M. Brophy
President & Chief Executive Officer	Principal Accounting Officer
(Principal Executive Officer)	(Principal Financial and Accounting Officer)
October 22, 2021	October 22, 2021

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Oct. 20, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	0-12015
Entity Registrant Name	HEALTHCARE SERVICES GROUP, INC.
Entity Incorporation, State Code	PA
I.R.S. Employer Identification No.	23-2018365
Entity Address, Address Line One	3220 Tillman Drive
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Bensalem
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19020
City Area Code	215
Local Phone Number	639-4274
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	HCSG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		74,539,000
Entity Central Index Key	0000731012
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 79,582	$ 139,330
Marketable securities, at fair value	125,583	125,012
Accounts and notes receivable, less allowance for doubtful accounts of $61,879 and $59,906 as of September 30, 2021 and December 31, 2020, respectively	289,725	255,474
Inventories and supplies	26,714	31,586
Prepaid expenses and other assets	44,460	21,001
Total current assets	566,064	572,403
Property and equipment, net	27,817	26,561
Goodwill	65,545	51,084
Other intangible assets, less accumulated amortization of $26,715 and $23,466 as of September 30, 2021 and December 31, 2020, respectively	17,039	18,187
Notes receivable — long–term portion, less allowance for doubtful accounts of $6,135 and $7,895 as of September 30, 2021 and December 31, 2020, respectively	30,651	34,417
Deferred compensation funding, at fair value	50,711	46,825
Deferred income taxes	35,776	35,554
Total assets	793,603	785,031
Current liabilities:
Accounts payable	50,493	52,239
Accrued payroll and related taxes	42,354	70,614
Other accrued expenses	36,843	17,797
Accrued insurance claims	24,164	21,610
Total current liabilities	153,854	162,260
Accrued insurance claims — long-term portion	63,135	60,818
Deferred compensation liability	50,747	46,827
Accrued payroll and related taxes - noncurrent	23,302	23,302
Lease liability — long-term portion	11,798	11,363
Other long-term liabilities	10,562	0
Commitments and contingencies (Note 14)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 100,000 shares authorized; 75,997 and 75,798 shares issued, and 74,565 and 74,485 shares outstanding as of September 30, 2021 and December 31, 2020, respectively	760	758
Additional paid-in capital	291,899	282,206
Retained earnings	197,550	200,893
Accumulated other comprehensive income, net of taxes	3,981	5,563
Common stock in treasury, at cost, 1,432 and 1,313 shares as of September 30, 2021 and December 31, 2020, respectively	(13,985)	(8,959)
Total stockholders’ equity	480,205	480,461
Total liabilities and stockholders’ equity	$ 793,603	$ 785,031

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts, current	$ 61,879	$ 59,906
Accumulated amortization of other intangible assets	26,715	23,466
Allowance for doubtful accounts, noncurrent	$ 6,135	$ 7,895
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	100,000,000	100,000,000
Common stock issued (in shares)	75,997,000	75,798,000
Common stock outstanding (in shares)	74,565,000	74,485,000
Common stock in treasury (in shares)	1,432,000	1,313,000

XML

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues	$ 415,590	$ 435,947	$ 1,221,512	$ 1,337,126
Operating costs and expenses:
Costs of services provided	364,822	365,443	1,037,852	1,140,116
Selling, general and administrative expense	38,780	37,337	128,818	108,819
Other income (expense):
Investment and other income, net	462	4,279	6,311	7,197
Interest expense	(329)	(314)	(1,017)	(1,062)
Income before income taxes	12,121	37,132	60,136	94,326
Income tax provision	2,581	9,488	16,378	23,391
Net income	$ 9,540	$ 27,644	$ 43,758	$ 70,935
Per share data:
Basic earnings per common share (in dollars per share)	$ 0.13	$ 0.37	$ 0.58	$ 0.95
Diluted earnings per common share (in dollars per share)	$ 0.13	$ 0.37	$ 0.58	$ 0.95
Weighted average number of common shares outstanding:
Basic (in shares)	74,943	74,700	74,983	74,684
Diluted (in shares)	75,076	74,777	75,170	74,768
Comprehensive income:
Net income	$ 9,540	$ 27,644	$ 43,758	$ 70,935
Other comprehensive income:
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(1,014)	873	(1,582)	1,996
Total comprehensive income	$ 8,526	$ 28,517	$ 42,176	$ 72,931

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income	$ 43,758	$ 70,935
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,961	10,752
Bad debt provision	10,790	6,756
Deferred income tax expense (benefit)	198	(8,247)
Share-based compensation expense	6,968	5,917
Amortization of premium on marketable securities	1,740	1,409
Unrealized gain on deferred compensation fund investments	(3,958)	(4,210)
Loss on sale of assets	1,157	0
Changes in operating assets and liabilities:
Accounts and notes receivable	(41,275)	22,440
Inventories and supplies	4,872	3,825
Prepaid expenses and other assets	(23,459)	(3,588)
Deferred compensation funding	72	488
Accounts payable and other accrued expenses	10,694	(9,104)
Accrued payroll, accrued and withheld payroll taxes	(26,085)	14,356
Income taxes payable	0	17,420
Accrued insurance claims	4,871	8,450
Deferred compensation liability	4,427	3,950
Net cash provided by operating activities	5,731	141,549
Cash flows from investing activities:
Disposals of fixed assets	201	475
Additions to property and equipment	(4,202)	(3,074)
Purchases of marketable securities	(16,683)	(8,242)
Sales of marketable securities	12,368	5,979
Cash paid for acquisition	(6,000)	0
Net cash used in investing activities	(14,316)	(4,862)
Cash flows from financing activities:
Dividends paid	(46,672)	(45,383)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan	69	69
Proceeds from the exercise of stock options	2,238	1,893
Purchases of treasury stock	(5,397)	0
Repayments of short-term borrowings	0	(10,000)
Payments of statutory withholding on net issuance of restricted stock units	(1,401)	(675)
Net cash used in financing activities	(51,163)	(54,096)
Net change in cash and cash equivalents	(59,748)	82,591
Cash and cash equivalents at beginning of the period	139,330	27,329
Cash and cash equivalents at end of the period	79,582	109,920
Supplemental disclosure of non-cash investing activities
Accrued variable consideration from acquisition of a business	$ 10,562	$ 0

XML

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Adjustment to adopt credit-loss guidance	[1]	Balance, January 1, 2020	Common Stock	Common Stock Balance, January 1, 2020	Additional Paid-in Capital	Additional Paid-in Capital Balance, January 1, 2020	Accumulated Other Comprehensive Income, net of taxes	Accumulated Other Comprehensive Income, net of taxes Balance, January 1, 2020	Retained Earnings	Retained Earnings Adjustment to adopt credit-loss guidance	[1]	Retained Earnings Balance, January 1, 2020	Treasury Stock	Treasury Stock Balance, January 1, 2020
Balance (in shares) at Dec. 31, 2019					75,557	75,557
Beginning balance at Dec. 31, 2019	$ 460,305	$ (32,099)		$ 428,206	$ 756	$ 756	$ 270,614	$ 270,614	$ 2,919	$ 2,919	$ 195,455	$ (32,099)		$ 163,356	$ (9,439)	$ (9,439)
Comprehensive income:
Net income	20,190										20,190
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(533)								(533)
Comprehensive income for the period	19,657
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					162
Exercise of stock options and other share-based compensation, net of shares tendered for payment	1,724				$ 1		1,723
Payment of statutory withholding on issuance of restricted stock units	(661)						(661)
Share-based compensation expense	1,822						1,822
Treasury shares issued for Deferred Compensation Plan funding and redemptions	528						417								111
Shares issued pursuant to Employee Stock Plan	1,835						1,329								506
Dividends paid and accrued	(15,142)										(15,142)
Shares issued pursuant to Dividend Reinvestment Plan	23						16								7
Other (in shares)					6
Other	187						187
Balance (in shares) at Mar. 31, 2020					75,725
Ending balance at Mar. 31, 2020	$ 438,179				$ 757		275,447		2,386		168,404				(8,815)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.20
Balance (in shares) at Dec. 31, 2019					75,557	75,557
Beginning balance at Dec. 31, 2019	$ 460,305	$ (32,099)		$ 428,206	$ 756	$ 756	270,614	$ 270,614	2,919	$ 2,919	195,455	$ (32,099)		$ 163,356	(9,439)	$ (9,439)
Comprehensive income:
Net income	70,935
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	1,996
Comprehensive income for the period	72,931
Balance (in shares) at Sep. 30, 2020					75,734
Ending balance at Sep. 30, 2020	464,750				$ 757		279,408		4,915		188,578				(8,908)
Balance (in shares) at Mar. 31, 2020					75,725
Beginning balance at Mar. 31, 2020	438,179				$ 757		275,447		2,386		168,404				(8,815)
Comprehensive income:
Net income	23,101										23,101
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	1,656								1,656
Comprehensive income for the period	24,757
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					7
Exercise of stock options and other share-based compensation, net of shares tendered for payment	138						138
Share-based compensation expense	1,830						1,830
Treasury shares issued for Deferred Compensation Plan funding and redemptions	(2)						51								(53)
Dividends paid and accrued	(15,237)										(15,237)
Shares issued pursuant to Dividend Reinvestment Plan	22						16								6
Balance (in shares) at Jun. 30, 2020					75,732
Ending balance at Jun. 30, 2020	$ 449,687				$ 757		277,482		4,042		176,268				(8,862)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.20
Net income	$ 27,644										27,644
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	873								873
Comprehensive income for the period	28,517
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					2
Exercise of stock options and other share-based compensation, net of shares tendered for payment	31						31
Payment of statutory withholding on issuance of restricted stock units	(14)						(14)
Share-based compensation expense	1,840						1,840
Treasury shares issued for Deferred Compensation Plan funding and redemptions	(1)						53								(54)
Dividends paid and accrued	(15,334)										(15,334)
Shares issued pursuant to Dividend Reinvestment Plan	24						16								8
Balance (in shares) at Sep. 30, 2020					75,734
Ending balance at Sep. 30, 2020	$ 464,750				$ 757		279,408		4,915		188,578				(8,908)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.20
Balance (in shares) at Dec. 31, 2020					75,798
Beginning balance at Dec. 31, 2020	$ 480,461				$ 758		282,206		5,563		200,893				(8,959)
Comprehensive income:
Net income	24,653										24,653
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(1,271)								(1,271)
Comprehensive income for the period	23,382
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					156
Exercise of stock options and other share-based compensation, net of shares tendered for payment	1,475				$ 2		1,473
Payment of statutory withholding on issuance of restricted stock units	(1,501)						(1,501)
Share-based compensation expense	2,104						2,104
Treasury shares issued for Deferred Compensation Plan funding and redemptions	509						545								(36)
Shares issued pursuant to Employee Stock Plan	2,052						1,554								498
Dividends paid and accrued	(15,526)										(15,526)
Shares issued pursuant to Dividend Reinvestment Plan	23						18								5
Other (in shares)					4
Other	123						123
Balance (in shares) at Mar. 31, 2021					75,958
Ending balance at Mar. 31, 2021	$ 493,102				$ 760		286,522		4,292		210,020				(8,492)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.21
Balance (in shares) at Dec. 31, 2020					75,798
Beginning balance at Dec. 31, 2020	$ 480,461				$ 758		282,206		5,563		200,893				(8,959)
Comprehensive income:
Net income	43,758
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(1,582)
Comprehensive income for the period	42,176
Balance (in shares) at Sep. 30, 2021					75,997
Ending balance at Sep. 30, 2021	480,205				$ 760		291,899		3,981		197,550				(13,985)
Balance (in shares) at Mar. 31, 2021					75,958
Beginning balance at Mar. 31, 2021	493,102				$ 760		286,522		4,292		210,020				(8,492)
Comprehensive income:
Net income	9,565										9,565
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	703								703
Comprehensive income for the period	10,268
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					11
Exercise of stock options and other share-based compensation, net of shares tendered for payment	380						380
Share-based compensation expense	2,159						2,159
Purchases of treasury stock	(1,835)														(1,835)
Treasury shares issued for Deferred Compensation Plan funding and redemptions	(1)						60								(61)
Dividends paid and accrued	(15,792)										(15,792)
Shares issued pursuant to Dividend Reinvestment Plan	23						17								6
Balance (in shares) at Jun. 30, 2021					75,969
Ending balance at Jun. 30, 2021	$ 488,304				$ 760		289,138		4,995		203,793				(10,382)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.21
Net income	$ 9,540										9,540
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	(1,014)								(1,014)
Comprehensive income for the period	8,526
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)					28
Exercise of stock options and other share-based compensation, net of shares tendered for payment	383						383
Payment of statutory withholding on issuance of restricted stock units	100						100
Share-based compensation expense	2,214						2,214
Purchases of treasury stock	(3,562)														(3,562)
Treasury shares issued for Deferred Compensation Plan funding and redemptions	0						50								(50)
Dividends paid and accrued	(15,783)										(15,783)
Shares issued pursuant to Dividend Reinvestment Plan	23						14								9
Balance (in shares) at Sep. 30, 2021					75,997
Ending balance at Sep. 30, 2021	$ 480,205				$ 760		$ 291,899		$ 3,981		$ 197,550				$ (13,985)
Comprehensive income:
Cash dividend paid per common share (in dollars per share)	$ 0.21

[1] See Note 4—Allowance for Doubtful Accounts regarding the new credit-loss guidance.

XML

Consolidated Statements of Stockholders' Equity (Parenthetical)	12 Months Ended
	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]

XML

Description of Business and Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Description of Business and Significant Accounting Policies

Note 1—Description of Business and Significant Accounting Policies

Nature of Operations

Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs.

The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility.

Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.

Unaudited Interim Financial Data

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2020 has been derived from the audited financial statements for the year ended December 31, 2020. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for any future period.

Use of Estimates in Financial Statements

In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.

Accounts and Notes Receivable

Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided.

Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss.

Refer to Note 3—Accounts and Notes Receivable herein for further information.

Allowance for Doubtful Accounts

The guidance under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”) became effective and was adopted by the Company prospectively as of January 1, 2020. In adopting ASC 326, the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables for its reporting of quarterly and annual financial results with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate the lifetime expected credit losses on such instruments and to record an allowance to offset the receivables. ASC 326 requires the recognition of credit losses that are expected based on existing accounts and notes receivable as compared to the incurred loss approach. Accordingly, credit losses under ASC 326 generally are recognized earlier in the life cycle of a receivable than under the Company’s previous incurred loss model. Modeling must be prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Under the previous incurred loss impairment model, credit losses were recognized when Management determined that it was more likely than not that a loss had been incurred and such loss was estimable.

Refer to Note 4—Allowance for Doubtful Accounts herein for further information.

Inventories and Supplies

Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.

Revenue Recognition

The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services. Refer to Note 2—Revenue herein for further information.

Leases

The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, in accordance with FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”). A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of September 30, 2021 and December 31, 2020, the Company was only the lessee of operating lease arrangements.

Refer to Note 7—Leases herein for further information.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not.

Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.

Earnings per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock units.

Share-Based Compensation

The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.

Identifiable Intangible Assets and Goodwill

Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value.

No impairment loss was recognized on the Company's intangible assets or goodwill during the nine months ended September 30, 2021 or 2020.

Concentrations of Credit Risk

The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At September 30, 2021 and December 31, 2020, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets.

The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.

XML

Revenue

9 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Revenue

Note 2—Revenue

The Company presents its consolidated revenues disaggregated by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 12—Segment Information herein as well as the information below regarding the Company’s reportable segments.

Housekeeping

Housekeeping accounted for $621.3 million and $675.4 million of the Company’s consolidated revenues for the nine months ended September 30, 2021 and 2020, respectively, which represented approximately 50.9% and 50.5% of the Company’s revenues in each respective period. The Housekeeping services include managing customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality-control procedures including continuous training and employee evaluation.

Dietary

Dietary services accounted for $600.2 million and $661.8 million of the Company’s consolidated revenues for the nine months ended September 30, 2021 and 2020, respectively, which represented approximately 49.1% and 49.5% of the Company’s revenues in each respective period. Dietary services consist of managing customers’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to customers. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.

Revenue Recognition

The Company’s revenues are derived from contracts with customers. The Company accounts for revenue from contracts with customers in accordance with ASC 606, and as such, the Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company is entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material.

The Company performs services and provides goods in accordance with its customers' contracts. Such contracts typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice, after an initial period of 60 to 120 days. A performance obligation is the unit of account under ASC 606 and is defined as a promise in a contract to transfer a distinct good or service to the customer. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services that are substantially the same and that have the same pattern of transfer to the customer. The Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the customers’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was $0.4 million and $0.1 million as of September 30, 2021 and December 31, 2020, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2020 were subsequently recognized as revenue during the nine months ended September 30, 2021.

The transaction price is the amount of consideration to which the Company is entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when the Company determines that there will not be a significant reversal in the amount of revenue recognized. The Company’s contracts generally do not contain significant financing components, as payment terms are less than one year.

The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represent a single performance obligation satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. As of September 30, 2021 and December 31, 2020, the value of the contract liabilities associated with customer prepayments was less than $0.1 million and $2.3 million, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2020 were subsequently recognized as revenue during the nine months ended September 30, 2021.

Transaction Price Allocated to Remaining Performance Obligations

The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

At September 30, 2021, the Company had $298.9 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 41.3% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consist of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.

XML

Accounts and Notes Receivable

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Accounts and Notes Receivable

Note 3—Accounts and Notes Receivable

The Company’s accounts and notes receivable balances consisted of the following as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Short-term
Accounts and notes receivable	$	351,604	$	315,380
Allowance for doubtful accounts	(61,879)		(59,906)
Total net short-term accounts and notes receivable	$	289,725	$	255,474
Long-term
Notes receivable	$	36,786	$	42,312
Allowance for doubtful accounts	(6,135)		(7,895)
Total net long-term notes receivable	$	30,651	$	34,417
Total net accounts and notes receivable	$	320,376	$	289,891

The Company makes credit decisions on a case-by-case basis after reviewing a number of qualitative and quantitative factors related to the specific customer as well as current industry variables that may impact that customer. There are a variety of factors that impact a customer’s ability to pay in accordance with the Company’s contracts. These factors include, but are not limited to, fluctuating census numbers, litigation costs and the customer’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the customer’s cash flows and its ability to make timely payments. However, the customer’s obligation to pay the Company in accordance with the contracts are not contingent upon the customer’s cash flow. Notwithstanding the Company’s efforts to minimize its credit risk exposure, the aforementioned factors, as well as other factors that impact customer cash flows or ability to make timely payments, could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition.

Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition, modification or termination of customer relationships. The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes to enhance the collectability of amounts due, by instituting definitive repayment plans and providing a means by which to further evidence the amounts owed. In addition, the Company may amend contracts from full service to management-only arrangements, or adjust contractual payment terms, to accommodate customers who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk.

XML

Allowance for Doubtful Accounts

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Allowance for Doubtful Accounts

Note 4—Allowance for Doubtful Accounts

In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition.

The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a triggering event such as bankruptcy. At the end of each period, the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable.

The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established, recognizing the environment of the long-term care industry, and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. Interest income from notes receivable for both the three months ended September 30, 2021 and 2020 was $0.3 million, respectively. Interest income from notes receivable for the nine months ended September 30, 2021 and 2020 was $1.0 million and $1.3 million, respectively.

As part of the Company’s adoption of ASC 326, there are additional disclosures required to be made on a class of financing receivable basis. The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the current nine month period ended September 30, 2021.

	Notes Receivable
	Amortized Cost Basis by Origination Year
	2021		2020		2019		2018		2017		Prior		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	11,414	$	8,181	$	2,060	$	18,980	$	21,289	$	1,560	$	63,484
Elevated risk notes receivable	$	—	$	—	$	617	$	—	$	723	$	1,374	$	2,714
Current-period gross write-offs	$	—	$	—	$	—	$	315	$	2,493	$	—	$	2,808
Current-period recoveries	—		—		(1)		—		—		(37)		(38)
Current-period net write-offs	$	—	$	—	$	(1)	$	315	$	2,493	$	(37)	$	2,770

The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of September 30, 2021:

	Age Analysis of Past-Due Notes Receivable as of September 30, 2021
	0-90 Days		91 - 180 Days		Greater than 181 Days		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	5,709	$	877	$	5,589	$	12,175
Elevated risk notes receivable	—		—		2,714		2,714
	$	5,709	$	877	$	8,303	$	14,889

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2021		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	50,243	$	(427)	$	4,230	$	54,046
Notes Receivable
Standard notes receivable	$	12,534	$	—	$	(149)	$	12,385
Elevated risk notes receivable	1,583		—		—		1,583
Total notes receivable	$	14,117	$	—	$	(149)	$	13,968
Total accounts and notes receivable	$	64,360	$	(427)	$	4,081	$	68,014

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2021, the Company collected an immaterial amount of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2020		Write-Offs1		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	66,299	$	(2,475)	$	967	$	64,791
Notes Receivable
Standard notes receivable	$	11,869	$	(253)	$	(132)	$	11,484
Elevated risk notes receivable	5,818		—		—		5,818
Total notes receivable	$	17,687	$	(253)	$	(132)	$	17,302
Total accounts and notes receivable	$	83,986	$	(2,728)	$	835	$	82,093

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2020, the Company collected $0.1 million of accounts receivables which had previously been written-off as uncollectible.

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the nine months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2020		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	51,052	$	(7,807)	$	10,801	$	54,046
Notes receivable
Standard notes receivable	$	13,258	$	(9)	$	(864)	$	12,385
Elevated risk notes receivable	3,491		(2,761)		853		1,583
Total notes receivable	$	16,749	$	(2,770)	$	(11)	$	13,968
Total accounts and notes receivable	$	67,801	$	(10,577)	$	10,790	$	68,014

1.Write-offs are shown net of recoveries. During the nine months ended September 30, 2021, the Company collected $0.1 million of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2019		Cumulative effect of ASC 326 adoption1		Write-Offs2		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	39,903	$	36,709	$	(16,871)	$	5,050	$	64,791
Notes receivable
Standard notes receivable	$	6,667	$	5,236	$	(1,974)	$	1,555	$	11,484
Elevated risk notes receivable	5,823		291		(447)		151		5,818
Total notes receivable	$	12,490	$	5,527	$	(2,421)	$	1,706	$	17,302
Total accounts and notes receivable	$	52,393	$	42,236	$	(19,292)	$	6,756	$	82,093

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.

2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables which had previously been written-off as uncollectible.

XML

Changes in Accumulated Other Comprehensive Income by Component

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Changes in Accumulated Other Comprehensive Income by Component

Note 5—Changes in Accumulated Other Comprehensive Income by Component

The Company's accumulated other comprehensive income consists of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following table provides a summary of the changes in accumulated other comprehensive income for the nine months ended September 30, 2021 and 2020:

	Unrealized Gains and Losses on Available-for-Sale Securities1
	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Accumulated other comprehensive income — beginning balance	$	5,563	$	2,919
Other comprehensive (loss) income before reclassifications	(1,421)		1,925
(Gains) losses reclassified from other comprehensive income2	(161)		71
Net current period other comprehensive (loss) income3	(1,582)		1,996
Accumulated other comprehensive income — ending balance	$	3,981	$	4,915

1.All amounts are net of tax

2.Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the nine months ended September 30, 2021, the Company recorded $0.2 million of realized gains from the sale of available-for-sale securities. For the nine months ended September 30, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information.

3.For the nine months ended September 30, 2021, the changes in other comprehensive income were net of a tax benefit of $0.4 million. For the nine months ended September 30, 2020, the changes in other comprehensive income were net of a tax expense of $0.5 million.

	Amounts Reclassified from Accumulated Other Comprehensive Income
	2021		2020
	(in thousands)
Three Months Ended September 30,
Losses from the sale of available-for-sale securities	$	(7)	$	(7)
Tax benefit	5		2
Net loss reclassified from accumulated other comprehensive income	$	(2)	$	(5)
Nine Months Ended September 30,
Gains (losses) from the sale of available-for-sale securities	$	221	$	(94)
Tax (expense) benefit	(60)		23
Net gain (loss) reclassified from accumulated other comprehensive income	$	161	$	(71)

XML

Property and Equipment

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Property and Equipment

Note 6—Property and Equipment

Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred.

The following table sets forth the amounts of property and equipment by each class of depreciable asset as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Housekeeping and dietary equipment	$	13,145	$	13,862
Computer hardware and software	5,402		6,015
Operating lease — right-of-use assets	32,032		26,074
Other1	1,601		1,581
Total property and equipment, at cost	52,180		47,532
Less accumulated depreciation	24,363		20,971
Total property and equipment, net	$	27,817	$	26,561

1.Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases.

Depreciation expense for both the three months ended September 30, 2021 and 2020 was $2.5 million. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $7.7 million and $7.6 million, respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2021, $1.6 million and $4.7 million related to the depreciation of the Company’s operating lease - right-of-use assets (“ROU Assets”), respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2020, $1.4 million and $4.2 million related to the depreciation of the Company’s operating lease - right-of-use assets (“ROU Assets”), respectively.

XML

Leases

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Leases

Note 7—Leases

The Company recognizes ROU Assets and lease liabilities (“Lease Liabilities”) for automobiles, office buildings, IT equipment, and small storage units for the temporary storage of operational equipment. The Company’s leases have remaining lease terms ranging from less than 1 year to 8 years, and have extension options ranging from 1 year to 5 years. Most leases include the option to terminate the lease within 1 year.

Upon adopting ASC 842, the Company made accounting policy elections using practical expedients offered under the guidance to combine lease and non-lease components within leasing arrangements and to recognize the payments associated with short-term leases in earnings on a straight-line basis over the lease term, with the cost associated with variable lease payments recognized when incurred. These accounting policy elections impact the value of the Company’s ROU Assets and Lease Liabilities. The value of the Company’s ROU Assets is determined as the non-depreciated fair value of its leasing arrangements and is recorded to Property and Equipment, net on the Company’s Consolidated Balance Sheets. The value of the Company’s Lease Liabilities is the present value of fixed lease payments not yet paid, discounted using either the rate implicit in the lease contract if that rate can be determined, or the Company’s incremental borrowing rate (“IBR”) and is recorded in Other accrued expenses and Lease liability — long-term portion on the Company’s Consolidated Balance Sheets. The Company’s IBR is determined as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

Any future lease payments that are not fixed based on the terms of the lease contract, or fluctuate based on a factor other than an index or rate, are considered variable lease payments and are not included in the value of the Company’s ROU Assets or Lease Liabilities. The Company's variable lease payments are mostly incurred from automobile leases and relate to miscellaneous transportation costs including repair costs, insurance, and terminal rental adjustments payments due at lease settlement. Such rental adjustment payments can result in a reduction to the Company's total variable lease payments.

Components of lease expense required by ASC 842 are presented below for the three and nine months ended September 30, 2021 and 2020.

	Three Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	1,629	$	1,404
Short-term lease cost	122		135
Variable lease cost	73		188
Total lease cost	$	1,824	$	1,727

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	4,547	$	4,153
Short-term lease cost	558		388
Variable lease cost	(458)		450
Total lease cost	$	4,647	$	4,991

Supplemental information required by ASC 842 is presented below for the nine months ended September 30, 2021 and 2020.

	Nine Months Ended September 30,
	2021			2020
	(dollar amounts in thousands)
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4,902		$	2,793
Weighted-average remaining lease term — operating leases	4.8 years			5.1 years
Weighted-average discount rate — operating leases	4.2		%	4.9		%

During the three and nine months ended September 30, 2021, the Company’s ROU Assets and Lease Liabilities were reduced by $0.3 million and $0.6 million, respectively, due to lease cancellations. During the three and nine months ended September 30, 2020, the Company's ROU Assets and Lease Liabilities were reduced by $0.1 million and $0.3 million, respectively, due to lease cancellations.

The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of September 30, 2021:

Period/Year	Operating Leases
	(in thousands)
October 1 to December 31, 2021	$	1,683
2022	6,131
2023	4,354
2024	2,225
2025	1,311
2026	1,337
Thereafter	2,867
Total minimum lease payments	$	19,908
Less: imputed lease discount	$	1,700
Present value of lease liabilities	$	18,208

XML

Other Intangible Assets

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Other Intangible Assets

Note 8—Other Intangible Assets

The Company’s other intangible assets consist of customer relationships, patents, non-compete agreements, and trademarks which were obtained through acquisitions and are recorded at their fair values at the date of acquisition. Intangible assets with determinable lives are amortized on a straight-line basis over their estimated useful lives. The weighted average amortization period of the Company's intangible assets was 9.9 years.

The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2021, the following five fiscal years and thereafter:

Period/Year	Total Amortization Expense
	(in thousands)
October 1 to December 31, 2021	$	1,105
2022	$	4,416
2023	$	3,420
2024	$	2,286
2025	$	2,286
2026	$	2,270
Thereafter	$	1,256

Amortization expense for the three and nine months ended September 30, 2021 was $1.1 million and $3.3 million, respectively. Amortization expense for the three and nine months ended September 30, 2020 was $1.0 million and $3.1 million, respectively.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 9—Fair Value Measurements

The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities and inventories) are recorded at cost in the Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations.

The Company’s marketable securities primarily consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in other comprehensive income (net of tax) within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the three and nine months ended September 30, 2021, the Company recorded unrealized losses, net of taxes of $1.0 million and $1.6 million on marketable securities, respectively. For the three and nine months ended September 30, 2020, the Company recorded unrealized gains, net of taxes of $0.9 million and $2.0 million on marketable securities, respectively.

For the three months ended September 30, 2021 and 2020, the Company received total proceeds, less the amount of interest received, of $0.3 million and $0.2 million, respectively, from sales of available-for-sale municipal bonds. For both the three months ended September 30, 2021 and 2020, these sales resulted in realized losses of less than $0.1 million. For the nine months ended September 30, 2021 and 2020, the Company received total proceeds, less the amount of interest received, of $12.4 million and $6.0 million, respectively, from sales of available-for-sale municipal bonds. For the nine months ended September 30, 2021 and 2020, these sales resulted in realized gains of $0.2 million and realized losses of $0.1 million, respectively, which were recorded in “Other income – Investment and other income, net” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period.

The investments under the funded deferred compensation plan are accounted for as trading securities and unrealized gains or losses are included in earnings. The fair value of these investments are determined based on quoted market prices (Level 1). For the three months ended September 30, 2021 and 2020, the Company recognized unrealized losses of $0.1 million and unrealized gains of $3.2 million, respectively, related to equity securities still held at the respective reporting dates. For the nine months ended September 30, 2021 and 2020, the Company's recognized unrealized gains of $4.0 million and $4.2 million, respectively, related to equity securities still held at the respective reporting dates.

The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of September 30, 2021 and December 31, 2020:

	As of September 30, 2021
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,583	$	125,583	$	—	$	125,583	$	—
Deferred compensation fund
Money Market1	$	2,934	$	2,934	$	—	$	2,934	$	—
Balanced and Lifestyle	11,922		11,922		11,922		—		—
Large Cap Growth	18,833		18,833		18,833		—		—
Small Cap Growth	6,010		6,010		6,010		—		—
Fixed Income	4,882		4,882		4,882		—		—
International	2,328		2,328		2,328		—		—
Mid Cap Growth	3,801		3,801		3,801		—		—
Deferred compensation fund	$	50,711	$	50,711	$	47,777	$	2,934	$	—

	As of December 31, 2020
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,012	$	125,012	$	—	$	125,012	$	—
Deferred compensation fund
Money Market1	$	3,006	$	3,006	$	—	$	3,006	$	—
Balanced and Lifestyle	10,815		10,815		10,815		—		—
Large Cap Growth	17,223		17,223		17,223		—		—
Small Cap Growth	5,337		5,337		5,337		—		—
Fixed Income	4,850		4,850		4,850		—		—
International	2,250		2,250		2,250		—		—
Mid Cap Growth	3,344		3,344		3,344		—		—
Deferred compensation fund	$	46,825	$	46,825	$	43,819	$	3,006	$	—

1.The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		Other-than-temporary Impairments
	(in thousands)
September 30, 2021
Type of security:
Municipal bonds — available-for-sale	$	120,543	$	5,316	$	(276)	$	125,583	$	—
Total debt securities	$	120,543	$	5,316	$	(276)	$	125,583	$	—
December 31, 2020
Type of security:
Municipal bonds — available-for-sale	$	117,970	$	7,043	$	(1)	$	125,012	$	—
Total debt securities	$	117,970	$	7,043	$	(1)	$	125,012	$	—

The following table summarizes the contractual maturities of debt securities held at September 30, 2021 and December 31, 2020, which are classified as marketable securities in the Consolidated Balance Sheets:

	Municipal Bonds — Available-for-Sale
Contractual maturity:	September 30, 2021		December 31, 2020
	(in thousands)
Maturing in one year or less	$	6,207	$	2,927
Maturing in second year through fifth year	32,788		26,324
Maturing in sixth year through tenth year	52,902		55,366
Maturing after ten years	33,686		40,395
Total debt securities	$	125,583	$	125,012

XML

Share-Based Compensation

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Share-Based Compensation

Note 10—Shared-Based Compensation

The components of the Company’s shared-based compensation expense for the nine months ended September 30, 2021 and 2020 are as follows:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Stock options	$	1,381	$	1,594
Restricted stock units and deferred stock units	4,797		3,898
Performance stock units	299		—
Employee Stock Purchase Plan	491		425
Total pre-tax share-based compensation expense charged against income1	$	6,968	$	5,917

1.Share-based compensation expense is recorded in cost of services and selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.

At September 30, 2021, the unrecognized compensation cost related to unvested stock options and awards was $20.0 million. The weighted average period over which these awards will vest is approximately 2.9 years.

2020 Omnibus Incentive Plan

On May 26, 2020, the Company adopted the 2020 Omnibus Incentive Plan (the “2020 Plan”) after approval by the Company's Shareholders at the Annual Meeting of Shareholders. The 2020 Plan provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, performance stock units, restricted stock units and other stock awards. The 2020 Plan seeks to encourage profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company's operating objectives.

As of September 30, 2021, there were 4.9 million shares of common stock reserved for issuance under the 2020 Plan, of which, 2.0 million are available for future grant. The amount of shares available for issuance under the 2020 Plan will increase when outstanding awards under the Company's Second Amended and Restated 2012 Equity Incentive Plan (the “2012 Plan”) are subsequently forfeited, terminated, lapsed, or satisfied thereunder in cash or property other than shares. No stock award will have a term in excess of 10 years. The Nominating, Compensation and Stock Option Committee (the “NCSO”) of the Board of Directors is responsible for determining the terms of the grants in accordance with the 2020 Plan.

Stock Options

A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2020 and changes during the nine months ended September 30, 2021 are as follows:

	Stock Options Outstanding
	Number of Shares	Weighted Average Exercise Price
	(in thousands)
December 31, 2020	2,098	$	33.35
Granted	207	$	28.45
Exercised	(98)	$	22.93
Forfeited	(1)	$	39.38
Expired	(10)	$	33.64
September 30, 2021	2,196	$	33.35

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2021 and 2020 was $7.01 and $4.65 per common share, respectively. The total intrinsic value of stock options exercised during the nine months ended September 30, 2021 and 2020 was $0.6 million and $0.9 million, respectively.

The fair value of stock option awards granted in 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021		2020
Risk-free interest rate	0.6	%	1.8	%
Weighted average expected life	6.6 years		6.6 years
Expected volatility	34.7	%	26.6	%
Dividend yield	2.9	%	3.2	%

The following table summarizes other information about the stock options at September 30, 2021:

	September 30, 2021
	(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value	$	900
Weighted average remaining contractual life	5.1 years
Exercisable:
Number of options	1,551
Weighted average exercise price	$	33.32
Aggregate intrinsic value	$	800
Weighted average remaining contractual life	4.0 years

Restricted Stock Units

The fair value of outstanding restricted stock units was determined based on the market price of the shares on the date of grant. During the nine months ended September 30, 2021, the Company granted 0.3 million restricted stock units to its employees with a weighted average grant date fair value of $28.53 per unit. During the nine months ended September 30, 2020, the Company granted 0.3 million restricted stock units with a weighted average grant date fair value of $24.43 per unit.

During the nine months ended September 30, 2021 and 2020, the Company did not grant any restricted stock.

A summary of the outstanding restricted stock units as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Restricted Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	561	$	33.31
Granted	262	$	28.53
Vested	(147)	$	35.48
Forfeited	(12)	$	29.88
September 30, 2021	664	$	31.01

Performance Stock Units

On January 4, 2021, the NCSO granted 35,000 Performance Stock Units (“PSUs”) to the Company's executive officers. Such PSUs are contingent upon the achievement of certain total shareholder return (“TSR”) targets as compared to the TSR of the S&P 400 MidCap Index and the participant's continued employment with the Company for the three year period ending December 31, 2023, the date at which such awards vest. The unrecognized share-based compensation cost of the TSR-based PSU awards at September 30, 2021 is $0.9 million and is expected to be recognized over a weighted-average period of 2.4 years.

A summary of the outstanding PSUs as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Performance Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	—	$	—
Granted	35	$	34.52
Vested	—	$	—
Forfeited	—	$	—
September 30, 2021	35	$	34.52

Deferred Stock Units

On June 4, 2021, the NCSO granted 10,000 Deferred Stock Units (“DSUs”) to the Company's non-employee directors. Each DSU award vests in one year. Once vested, the recipient shall be entitled to receive a lump sum payment of a number of shares equal to the total number of DSUs issued to such recipient upon the first to occur of (i) the five year anniversary of the date of grant, (ii) the recipient's death, disability or separation of service from the Board, or (iii) a change of control (as defined by the 2020 Plan). The unrecognized share-based compensation cost of the DSU awards at September 30, 2021 is $0.2 million and is expected to be recognized over a weighted-average period of 0.7 years.

Employee Stock Purchase Plan

The Company’s Employee Stock Purchase Plan (“ESPP”) is currently available through 2026 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day.

Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 2.1 million shares available for future grant at September 30, 2021.

The expense associated with the options granted under the ESPP during the nine months ended September 30, 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021	2020
Risk-free interest rate	0.1%	1.6%
Weighted average expected life (years)	1.0	1.0
Expected volatility	61.7%	42.0%
Dividend yield	2.9%	3.3%

Deferred Compensation Plan

The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP allows participants to defer a portion of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a match of a portion of their deferral in the form of the Company’s common stock based on the then-current market value. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.3 million shares available for future grant at September 30, 2021. At the time of issuance, such shares are accounted for at cost as treasury stock.

The following table summarizes information about the SERP during the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
SERP expense 1	$	458	$	444
Unrealized gain recorded in SERP liability account	$	3,990	$	3,973

1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Note 11—Income Taxes

The Company’s annual effective tax rate is impacted by the tax effects of option exercises, vested awards, and the payment pertaining to the settlement with the Securities and Exchange Commission (“SEC”) to resolve its investigation, which are all treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on the Company’s income tax provision through the nine months ended September 30, 2021 for such discrete items was approximately $2.2 million.

Differences between the effective tax rate and the applicable U.S. federal statutory rate arise primarily from the effect of state and local income taxes, share-based compensation and tax credits available to the Company. The actual 2021 effective tax rate will likely vary from the estimate depending on the actual operating income earned with availability of tax credits and the exercise of stock options and vesting of share-based awards.

The Company accounts for income taxes using the asset and liability method, which results in recognizing income tax expense based on the amount of income taxes payable or refundable for the current year. Additionally, the Company regularly evaluates the tax positions taken or expected to be taken resulting from financial statement recognition of certain items. Based on the evaluation, there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The evaluation was performed for the tax years ended December 31, 2017 through 2020 (with regard to U.S. federal income tax returns) and December 31, 2016 through 2020 (with regard to various state and local income tax returns), the tax years which remain subject to examination by major tax jurisdictions as of September 30, 2021.

The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense.

XML

Segment Information

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Segment Information

Note 12—Segment Information

The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve a similar customer base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete contracts, specific to each reportable segment.

The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Revenues
Housekeeping	$	203,379	$	223,423	$	621,278	$	675,366
Dietary	212,211		212,524		600,234		661,760
Total	$	415,590	$	435,947	$	1,221,512	$	1,337,126
Income before income taxes
Housekeeping	$	17,237	$	24,784	$	68,025	$	73,983
Dietary	7,259		19,630		41,075		52,627
Corporate and eliminations1	(12,375)		(7,282)		(48,964)		(32,284)
Total	$	12,121	$	37,132	$	60,136	$	94,326

1.Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.

XML

Earnings Per Common Share

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Common Share

Note 13—Earnings Per Common Share

Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options, restricted stock units, and performance stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Numerator for basic and diluted earnings per share:
Net income	$	9,540	$	27,644	$	43,758	$	70,935
Denominator:
Weighted average number of common shares outstanding - basic	74,943		74,700		74,983		74,684
Effect of dilutive securities 1	133		77		187		84
Weighted average number of common shares outstanding - diluted	75,076		74,777		75,170		74,768
Basic earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95
Diluted earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95

1.Certain outstanding equity awards are anti-dilutive and therefore excluded from the calculation of the weighted average number of diluted common shares outstanding.

Anti-dilutive outstanding equity awards under share-based compensation plans were as follows:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
	(in thousands)
Anti-dilutive	2,184	2,244	1,788	2,145

XML

Other Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies Disclosure [Abstract]

Other Contingencies

Note 14—Other Contingencies

Line of Credit

At September 30, 2021, the Company had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a float rate, based on the Company’s leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). As of September 30, 2021 and December 31, 2020, there were no borrowings under the line of credit. The line of credit requires the Company to satisfy two financial covenants, with which the Company is in compliance as of September 30, 2021. The line of credit expires on December 21, 2023.

At September 30, 2021, the Company also had outstanding $64.9 million in irrevocable standby letters of credit, which relate to payment obligations under the Company’s insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $64.9 million to $410.1 million at September 30, 2021. The letters of credit expire on January 4, 2022.

Tax Jurisdictions and Matters

The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities.

The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters.

Legal Proceedings

The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. In accordance with FASB ASC 450 – Contingencies (“ASC 450”), as the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In accordance with ASC 450, the Company does not accrue for contingent losses that, in its judgment, are considered to be reasonably possible but not probable. In the event the Company determines that adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides disclosure regarding the matter, including a range of possible loss when the exposure is estimable, as required by ASC 450.

As previously disclosed, the Securities and Exchange Commission (the “SEC”) conducted an investigation into the Company’s earnings per share (“EPS”) calculation practices. Following receipt of a letter from the SEC in November 2017 regarding its inquiry into those practices and a subpoena in March 2018, the Company authorized King & Spalding to conduct an internal investigation, under the direction of the Company’s Audit Committee, into matters related to the SEC subpoena. This investigation was completed in March 2019, and the Company continued to cooperate with the SEC’s investigation and document requests after that time. The Company, its former Chief Financial Officer (now current Chief Administrative Officer), and its Controller reached a settlement with the SEC, which was approved by the SEC commissioners and publicly announced on August 24, 2021. The Company and the individuals neither admitted nor denied the findings in the Commission's order, which stated, among other things, that during certain quarters between 2014 and 2015, the Company failed to timely record the financial impact of certain loss contingencies and maintain accurate books, records and sufficient internal account controls. Under the terms of the settlement, the Company paid a $6.0 million civil monetary penalty during the third quarter of 2021.

On March 22, 2019, a putative shareholder class action lawsuit was filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania, seeking unspecified monetary damages and other relief on behalf of the plaintiff class. The initial complaint, which was filed by a plaintiff purportedly on behalf of all purchasers of the Company’s securities between April 11, 2017 and March 4, 2019 (the “Class Period”), alleges violations of the federal securities laws in connection with the matters related to the Company’s EPS calculation practices. On September 17, 2019, the complaint was amended to, among other things, extend the Class Period to cover the period between April 8, 2014 and March 4, 2019, and to name additional individuals affiliated with the Company as defendants.

On March 17, 2021, the parties reached an agreement in principle to settle the action on a class-wide basis. On June 30, 2021, the plaintiff filed an unopposed motion for an order preliminarily approving a proposed class action settlement, preliminarily certifying the settlement class, and approving notice to the settlement class. On September 15, 2021, the Court entered an order preliminarily approving the $16.8 million settlement and providing for notice to settlement class members. Our insurance carriers have agreed to pay the entirety of the settlement amount upon court approval of the settlement. As of March 31, 2021, the associated contingency was included within the “Other accrued expenses” and “Prepaid expenses and other assets” captions on the Company's Consolidated Balance Sheet. Refer to Note 15—Subsequent Events herein for further information.

The Company continues to vigorously defend against all active litigation claims asserted. Any of the foregoing matters could result in substantial costs to the Company, divert management’s attention and resources, and adversely affect the Company’s business condition or harm its reputation, regardless of their merit or outcome. In addition, the uncertainty of the pending lawsuits or potential filing of additional lawsuits could lead to more volatility and a reduction in the Company’s stock price.

Government RegulationsThe Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care many of whom have been significantly impacted by COVID-19. For those customers who were impacted, the pandemic has resulted in increased operating costs, reductions in new resident admitants, and reduced census. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or additional changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. There have been several enacted and proposed federal and state relief measures as a result of COVID-19 which should provide support for these customers during this pandemic, however, the full benefit of any such programs would not be realized until these programs are fully implemented, government agencies issue applicable regulations or guidance and such relief is provided.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 15—Subsequent Events

On October 15, 2021 the Company’s directors’ and officers’ liability insurance carriers paid a $16.8 million settlement to resolve a putative shareholder class action lawsuit originally filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania on March 22, 2019.

XML

Description of Business and Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Nature of Operations

Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs.

The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.

The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).

Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility.

Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.

Unaudited Interim Financial Data

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2020 has been derived from the audited financial statements for the year ended December 31, 2020. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for any future period.

Use of Estimates in Financial Statements

In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.

Accounts and Notes Receivable

Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided.

Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss.

Allowance for Doubtful Accounts

The guidance under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”) became effective and was adopted by the Company prospectively as of January 1, 2020. In adopting ASC 326, the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables for its reporting of quarterly and annual financial results with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate the lifetime expected credit losses on such instruments and to record an allowance to offset the receivables. ASC 326 requires the recognition of credit losses that are expected based on existing accounts and notes receivable as compared to the incurred loss approach. Accordingly, credit losses under ASC 326 generally are recognized earlier in the life cycle of a receivable than under the Company’s previous incurred loss model. Modeling must be prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Under the previous incurred loss impairment model, credit losses were recognized when Management determined that it was more likely than not that a loss had been incurred and such loss was estimable.

Inventories and Supplies

Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.

Revenue Recognition

The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services.

Leases

The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, in accordance with FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”). A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of September 30, 2021 and December 31, 2020, the Company was only the lessee of operating lease arrangements.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not. Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.

Earnings per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock units.

Share-Based Compensation

The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.

Identifiable Intangible Assets and Goodwill

Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value.

Concentrations of Credit Risk

The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At September 30, 2021 and December 31, 2020, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets.

The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.

Segments

The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

XML

Accounts and Notes Receivable (Tables)

9 Months Ended

Sep. 30, 2021

Receivables [Abstract]

Schedule of Accounts and Notes Receivable

The Company’s accounts and notes receivable balances consisted of the following as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Short-term
Accounts and notes receivable	$	351,604	$	315,380
Allowance for doubtful accounts	(61,879)		(59,906)
Total net short-term accounts and notes receivable	$	289,725	$	255,474
Long-term
Notes receivable	$	36,786	$	42,312
Allowance for doubtful accounts	(6,135)		(7,895)
Total net long-term notes receivable	$	30,651	$	34,417
Total net accounts and notes receivable	$	320,376	$	289,891

XML

Allowance for Doubtful Accounts (Tables)

3 Months Ended

9 Months Ended

Sep. 30, 2020

Sep. 30, 2021

Receivables [Abstract]

Notes Receivable Disaggregated by Vintage Year

The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the current nine month period ended September 30, 2021.

	Notes Receivable
	Amortized Cost Basis by Origination Year
	2021		2020		2019		2018		2017		Prior		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	11,414	$	8,181	$	2,060	$	18,980	$	21,289	$	1,560	$	63,484
Elevated risk notes receivable	$	—	$	—	$	617	$	—	$	723	$	1,374	$	2,714
Current-period gross write-offs	$	—	$	—	$	—	$	315	$	2,493	$	—	$	2,808
Current-period recoveries	—		—		(1)		—		—		(37)		(38)
Current-period net write-offs	$	—	$	—	$	(1)	$	315	$	2,493	$	(37)	$	2,770

Age Analysis of Past-Due Note Receivable

The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of September 30, 2021:

	Age Analysis of Past-Due Notes Receivable as of September 30, 2021
	0-90 Days		91 - 180 Days		Greater than 181 Days		Total
	(in thousands)
Notes Receivable
Standard notes receivable	$	5,709	$	877	$	5,589	$	12,175
Elevated risk notes receivable	—		—		2,714		2,714
	$	5,709	$	877	$	8,303	$	14,889

Schedule of Changes in Allowance for Doubtful Accounts

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2021		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	50,243	$	(427)	$	4,230	$	54,046
Notes Receivable
Standard notes receivable	$	12,534	$	—	$	(149)	$	12,385
Elevated risk notes receivable	1,583		—		—		1,583
Total notes receivable	$	14,117	$	—	$	(149)	$	13,968
Total accounts and notes receivable	$	64,360	$	(427)	$	4,081	$	68,014

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2021, the Company collected an immaterial amount of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2020		Write-Offs1		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	66,299	$	(2,475)	$	967	$	64,791
Notes Receivable
Standard notes receivable	$	11,869	$	(253)	$	(132)	$	11,484
Elevated risk notes receivable	5,818		—		—		5,818
Total notes receivable	$	17,687	$	(253)	$	(132)	$	17,302
Total accounts and notes receivable	$	83,986	$	(2,728)	$	835	$	82,093

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2020, the Company collected $0.1 million of accounts receivables which had previously been written-off as uncollectible.

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the nine months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2020		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	51,052	$	(7,807)	$	10,801	$	54,046
Notes receivable
Standard notes receivable	$	13,258	$	(9)	$	(864)	$	12,385
Elevated risk notes receivable	3,491		(2,761)		853		1,583
Total notes receivable	$	16,749	$	(2,770)	$	(11)	$	13,968
Total accounts and notes receivable	$	67,801	$	(10,577)	$	10,790	$	68,014

1.Write-offs are shown net of recoveries. During the nine months ended September 30, 2021, the Company collected $0.1 million of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2019		Cumulative effect of ASC 326 adoption1		Write-Offs2		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	39,903	$	36,709	$	(16,871)	$	5,050	$	64,791
Notes receivable
Standard notes receivable	$	6,667	$	5,236	$	(1,974)	$	1,555	$	11,484
Elevated risk notes receivable	5,823		291		(447)		151		5,818
Total notes receivable	$	12,490	$	5,527	$	(2,421)	$	1,706	$	17,302
Total accounts and notes receivable	$	52,393	$	42,236	$	(19,292)	$	6,756	$	82,093

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.

2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables which had previously been written-off as uncollectible.

Schedule of Changes in Allowance for Notes Receivable

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2021		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	50,243	$	(427)	$	4,230	$	54,046
Notes Receivable
Standard notes receivable	$	12,534	$	—	$	(149)	$	12,385
Elevated risk notes receivable	1,583		—		—		1,583
Total notes receivable	$	14,117	$	—	$	(149)	$	13,968
Total accounts and notes receivable	$	64,360	$	(427)	$	4,081	$	68,014

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2021, the Company collected an immaterial amount of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	June 30, 2020		Write-Offs1		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	66,299	$	(2,475)	$	967	$	64,791
Notes Receivable
Standard notes receivable	$	11,869	$	(253)	$	(132)	$	11,484
Elevated risk notes receivable	5,818		—		—		5,818
Total notes receivable	$	17,687	$	(253)	$	(132)	$	17,302
Total accounts and notes receivable	$	83,986	$	(2,728)	$	835	$	82,093

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2020, the Company collected $0.1 million of accounts receivables which had previously been written-off as uncollectible.

The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the nine months ended September 30, 2021 and 2020.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2020		Write-Offs1		Bad Debt Expense		September 30, 2021
	(in thousands)
Accounts receivable	$	51,052	$	(7,807)	$	10,801	$	54,046
Notes receivable
Standard notes receivable	$	13,258	$	(9)	$	(864)	$	12,385
Elevated risk notes receivable	3,491		(2,761)		853		1,583
Total notes receivable	$	16,749	$	(2,770)	$	(11)	$	13,968
Total accounts and notes receivable	$	67,801	$	(10,577)	$	10,790	$	68,014

1.Write-offs are shown net of recoveries. During the nine months ended September 30, 2021, the Company collected $0.1 million of accounts receivables and notes receivables which had previously been written-off as uncollectible.

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2019		Cumulative effect of ASC 326 adoption1		Write-Offs2		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	39,903	$	36,709	$	(16,871)	$	5,050	$	64,791
Notes receivable
Standard notes receivable	$	6,667	$	5,236	$	(1,974)	$	1,555	$	11,484
Elevated risk notes receivable	5,823		291		(447)		151		5,818
Total notes receivable	$	12,490	$	5,527	$	(2,421)	$	1,706	$	17,302
Total accounts and notes receivable	$	52,393	$	42,236	$	(19,292)	$	6,756	$	82,093

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.

2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables which had previously been written-off as uncollectible.

Schedule of Cumulative Effect of Initially Applying New Guidance

	Allowance for doubtful accounts
Portfolio Segment:	December 31, 2019		Cumulative effect of ASC 326 adoption1		Write-Offs2		Bad Debt Expense		September 30, 2020
	(in thousands)
Accounts receivable	$	39,903	$	36,709	$	(16,871)	$	5,050	$	64,791
Notes receivable
Standard notes receivable	$	6,667	$	5,236	$	(1,974)	$	1,555	$	11,484
Elevated risk notes receivable	5,823		291		(447)		151		5,818
Total notes receivable	$	12,490	$	5,527	$	(2,421)	$	1,706	$	17,302
Total accounts and notes receivable	$	52,393	$	42,236	$	(19,292)	$	6,756	$	82,093

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.

2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables which had previously been written-off as uncollectible.

XML

Changes in Accumulated Other Comprehensive Income by Component (Tables)

9 Months Ended

Sep. 30, 2021

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income

The following table provides a summary of the changes in accumulated other comprehensive income for the nine months ended September 30, 2021 and 2020:

	Unrealized Gains and Losses on Available-for-Sale Securities1
	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Accumulated other comprehensive income — beginning balance	$	5,563	$	2,919
Other comprehensive (loss) income before reclassifications	(1,421)		1,925
(Gains) losses reclassified from other comprehensive income2	(161)		71
Net current period other comprehensive (loss) income3	(1,582)		1,996
Accumulated other comprehensive income — ending balance	$	3,981	$	4,915

1.All amounts are net of tax

2.Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the nine months ended September 30, 2021, the Company recorded $0.2 million of realized gains from the sale of available-for-sale securities. For the nine months ended September 30, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information.

3.For the nine months ended September 30, 2021, the changes in other comprehensive income were net of a tax benefit of $0.4 million. For the nine months ended September 30, 2020, the changes in other comprehensive income were net of a tax expense of $0.5 million.

Reclassification out of Accumulated Other Comprehensive Income

	Amounts Reclassified from Accumulated Other Comprehensive Income
	2021		2020
	(in thousands)
Three Months Ended September 30,
Losses from the sale of available-for-sale securities	$	(7)	$	(7)
Tax benefit	5		2
Net loss reclassified from accumulated other comprehensive income	$	(2)	$	(5)
Nine Months Ended September 30,
Gains (losses) from the sale of available-for-sale securities	$	221	$	(94)
Tax (expense) benefit	(60)		23
Net gain (loss) reclassified from accumulated other comprehensive income	$	161	$	(71)

XML

Property and Equipment (Tables)

9 Months Ended

Sep. 30, 2021

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

The following table sets forth the amounts of property and equipment by each class of depreciable asset as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(in thousands)
Housekeeping and dietary equipment	$	13,145	$	13,862
Computer hardware and software	5,402		6,015
Operating lease — right-of-use assets	32,032		26,074
Other1	1,601		1,581
Total property and equipment, at cost	52,180		47,532
Less accumulated depreciation	24,363		20,971
Total property and equipment, net	$	27,817	$	26,561

1.Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases.

XML

Leases (Tables)

9 Months Ended

Sep. 30, 2021

Leases [Abstract]

Components of Lease Expense

Components of lease expense required by ASC 842 are presented below for the three and nine months ended September 30, 2021 and 2020.

	Three Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	1,629	$	1,404
Short-term lease cost	122		135
Variable lease cost	73		188
Total lease cost	$	1,824	$	1,727

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Lease cost
Operating lease cost	$	4,547	$	4,153
Short-term lease cost	558		388
Variable lease cost	(458)		450
Total lease cost	$	4,647	$	4,991

Supplemental Information Required by ASC 842

Supplemental information required by ASC 842 is presented below for the nine months ended September 30, 2021 and 2020.

	Nine Months Ended September 30,
	2021			2020
	(dollar amounts in thousands)
Other information
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	4,902		$	2,793
Weighted-average remaining lease term — operating leases	4.8 years			5.1 years
Weighted-average discount rate — operating leases	4.2		%	4.9		%

Schedule of Future Minimum Lease Payments

The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of September 30, 2021:

Period/Year	Operating Leases
	(in thousands)
October 1 to December 31, 2021	$	1,683
2022	6,131
2023	4,354
2024	2,225
2025	1,311
2026	1,337
Thereafter	2,867
Total minimum lease payments	$	19,908
Less: imputed lease discount	$	1,700
Present value of lease liabilities	$	18,208

XML

Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2021

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Estimated Amortization Expense For Intangibles Subject To Amortization

The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2021, the following five fiscal years and thereafter:

Period/Year	Total Amortization Expense
	(in thousands)
October 1 to December 31, 2021	$	1,105
2022	$	4,416
2023	$	3,420
2024	$	2,286
2025	$	2,286
2026	$	2,270
Thereafter	$	1,256

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Disclosures [Abstract]

Schedule of Fair Value Measurements

The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of September 30, 2021 and December 31, 2020:

	As of September 30, 2021
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,583	$	125,583	$	—	$	125,583	$	—
Deferred compensation fund
Money Market1	$	2,934	$	2,934	$	—	$	2,934	$	—
Balanced and Lifestyle	11,922		11,922		11,922		—		—
Large Cap Growth	18,833		18,833		18,833		—		—
Small Cap Growth	6,010		6,010		6,010		—		—
Fixed Income	4,882		4,882		4,882		—		—
International	2,328		2,328		2,328		—		—
Mid Cap Growth	3,801		3,801		3,801		—		—
Deferred compensation fund	$	50,711	$	50,711	$	47,777	$	2,934	$	—

	As of December 31, 2020
					Fair Value Measurement Using:
	Carrying Amount		Total Fair Value		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in thousands)
Financial Assets:
Marketable securities
Municipal bonds — available-for-sale	$	125,012	$	125,012	$	—	$	125,012	$	—
Deferred compensation fund
Money Market1	$	3,006	$	3,006	$	—	$	3,006	$	—
Balanced and Lifestyle	10,815		10,815		10,815		—		—
Large Cap Growth	17,223		17,223		17,223		—		—
Small Cap Growth	5,337		5,337		5,337		—		—
Fixed Income	4,850		4,850		4,850		—		—
International	2,250		2,250		2,250		—		—
Mid Cap Growth	3,344		3,344		3,344		—		—
Deferred compensation fund	$	46,825	$	46,825	$	43,819	$	3,006	$	—

1.The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.

Schedule of Marketable Debt Securities

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value		Other-than-temporary Impairments
	(in thousands)
September 30, 2021
Type of security:
Municipal bonds — available-for-sale	$	120,543	$	5,316	$	(276)	$	125,583	$	—
Total debt securities	$	120,543	$	5,316	$	(276)	$	125,583	$	—
December 31, 2020
Type of security:
Municipal bonds — available-for-sale	$	117,970	$	7,043	$	(1)	$	125,012	$	—
Total debt securities	$	117,970	$	7,043	$	(1)	$	125,012	$	—

Schedule of Contractual Maturities of Available for Sale Investments

The following table summarizes the contractual maturities of debt securities held at September 30, 2021 and December 31, 2020, which are classified as marketable securities in the Consolidated Balance Sheets:

	Municipal Bonds — Available-for-Sale
Contractual maturity:	September 30, 2021		December 31, 2020
	(in thousands)
Maturing in one year or less	$	6,207	$	2,927
Maturing in second year through fifth year	32,788		26,324
Maturing in sixth year through tenth year	52,902		55,366
Maturing after ten years	33,686		40,395
Total debt securities	$	125,583	$	125,012

XML

Share-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

The components of the Company’s shared-based compensation expense for the nine months ended September 30, 2021 and 2020 are as follows:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
Stock options	$	1,381	$	1,594
Restricted stock units and deferred stock units	4,797		3,898
Performance stock units	299		—
Employee Stock Purchase Plan	491		425
Total pre-tax share-based compensation expense charged against income1	$	6,968	$	5,917

1.Share-based compensation expense is recorded in cost of services and selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.

Summary of Other Information of Stock Option Plans

A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2020 and changes during the nine months ended September 30, 2021 are as follows:

	Stock Options Outstanding
	Number of Shares	Weighted Average Exercise Price
	(in thousands)
December 31, 2020	2,098	$	33.35
Granted	207	$	28.45
Exercised	(98)	$	22.93
Forfeited	(1)	$	39.38
Expired	(10)	$	33.64
September 30, 2021	2,196	$	33.35

Assumption For Fair Value of Options Granted

The fair value of stock option awards granted in 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021		2020
Risk-free interest rate	0.6	%	1.8	%
Weighted average expected life	6.6 years		6.6 years
Expected volatility	34.7	%	26.6	%
Dividend yield	2.9	%	3.2	%

Summarized Information of Stock Options Outstanding

The following table summarizes other information about the stock options at September 30, 2021:

	September 30, 2021
	(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value	$	900
Weighted average remaining contractual life	5.1 years
Exercisable:
Number of options	1,551
Weighted average exercise price	$	33.32
Aggregate intrinsic value	$	800
Weighted average remaining contractual life	4.0 years

Summary of Outstanding Restricted Stock Units

A summary of the outstanding restricted stock units as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Restricted Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	561	$	33.31
Granted	262	$	28.53
Vested	(147)	$	35.48
Forfeited	(12)	$	29.88
September 30, 2021	664	$	31.01

Summary of Outstanding Performance Stock Units

A summary of the outstanding PSUs as of December 31, 2020 and changes during the nine months ended September 30, 2021 is as follows:

	Performance Stock Units
	Number	Weighted Average Grant Date Fair Value
	(in thousands)
December 31, 2020	—	$	—
Granted	35	$	34.52
Vested	—	$	—
Forfeited	—	$	—
September 30, 2021	35	$	34.52

Schedule of Options Granted Estimated Expense Valuation Assumptions

The expense associated with the options granted under the ESPP during the nine months ended September 30, 2021 and 2020 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

	Nine Months Ended September 30,
	2021	2020
Risk-free interest rate	0.1%	1.6%
Weighted average expected life (years)	1.0	1.0
Expected volatility	61.7%	42.0%
Dividend yield	2.9%	3.3%

Summary of ESPP Annual Offerings

The following table summarizes information about the SERP during the nine months ended September 30, 2021 and 2020:

	Nine Months Ended September 30,
	2021		2020
	(in thousands)
SERP expense 1	$	458	$	444
Unrealized gain recorded in SERP liability account	$	3,990	$	3,973

1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Information of Reportable Segments

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Revenues
Housekeeping	$	203,379	$	223,423	$	621,278	$	675,366
Dietary	212,211		212,524		600,234		661,760
Total	$	415,590	$	435,947	$	1,221,512	$	1,337,126
Income before income taxes
Housekeeping	$	17,237	$	24,784	$	68,025	$	73,983
Dietary	7,259		19,630		41,075		52,627
Corporate and eliminations1	(12,375)		(7,282)		(48,964)		(32,284)
Total	$	12,121	$	37,132	$	60,136	$	94,326

1.Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.

XML

Earnings Per Common Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Schedule of Weighted Average Number of Shares

The table below reconciles the weighted-average basic and diluted common shares outstanding:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)
Numerator for basic and diluted earnings per share:
Net income	$	9,540	$	27,644	$	43,758	$	70,935
Denominator:
Weighted average number of common shares outstanding - basic	74,943		74,700		74,983		74,684
Effect of dilutive securities 1	133		77		187		84
Weighted average number of common shares outstanding - diluted	75,076		74,777		75,170		74,768
Basic earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95
Diluted earnings per share:	$	0.13	$	0.37	$	0.58	$	0.95

1.Certain outstanding equity awards are anti-dilutive and therefore excluded from the calculation of the weighted average number of diluted common shares outstanding.

Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans

Anti-dilutive outstanding equity awards under share-based compensation plans were as follows:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
	(in thousands)
Anti-dilutive	2,184	2,244	1,788	2,145

XML

Description of Business and Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2021 USD ($) segment financial_institution	Sep. 30, 2020 USD ($)	Dec. 31, 2020 financial_institution
Schedule of Accounting Policies [Line Items]
Renewal term	1 year
Number of reportable segments | segment	2
Amortization period of inventories and supplies	24 months
Goodwill and intangible asset impairment | $	$ 0	$ 0
Number of financial institutions holding cash and cash equivalents and marketable securities | financial_institution	1		1
Minimum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	30 days
Initial period preceding cancellation notice	60 days
Typically promissory notes maturity	1 year
Maximum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	90 days
Initial period preceding cancellation notice	120 days
Typically promissory notes maturity	3 years

XML

Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 415,590	$ 435,947	$ 1,221,512	$ 1,337,126
Renewal term			1 year
Description of timing			The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.At September 30, 2021, the Company had $298.9 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 41.3% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consist of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.
Transferred at point in time
Disaggregation of Revenue [Line Items]
Contract liabilities (less than for September 30, 2021)	400		$ 400		$ 100
Transferred over time
Disaggregation of Revenue [Line Items]
Contract liabilities (less than for September 30, 2021)	100		$ 100		$ 2,300
Minimum
Disaggregation of Revenue [Line Items]
Cancellation notice period			30 days
Initial period preceding cancellation notice			60 days
Maximum
Disaggregation of Revenue [Line Items]
Cancellation notice period			90 days
Initial period preceding cancellation notice			120 days
Housekeeping
Disaggregation of Revenue [Line Items]
Revenue	203,379	223,423	$ 621,278	$ 675,366
Percent of revenue			50.90%	50.50%
Dietary
Disaggregation of Revenue [Line Items]
Revenue	$ 212,211	$ 212,524	$ 600,234	$ 661,760
Percent of revenue			49.10%	49.50%

XML

Revenue - Transaction Price Allocated to Remaining Performance Obligations (Details) $ in Millions	Sep. 30, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Remaining performance obligation	$ 298.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation percent	41.30%
Revenue, remaining performance obligation period	12 months

XML

Accounts and Notes Receivable - Schedule of Accounts and Notes Receivable (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Short-term
Accounts and notes receivable	$ 351,604	$ 315,380
Allowance for doubtful accounts	(61,879)	(59,906)
Total net short-term accounts and notes receivable	289,725	255,474
Long-term
Notes receivable	36,786	42,312
Allowance for doubtful accounts	(6,135)	(7,895)
Total net long-term notes receivable	30,651	34,417
Total net accounts and notes receivable	$ 320,376	$ 289,891

XML

Allowance for Doubtful Accounts - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Receivables [Abstract]
Interest income	$ 0.3	$ 0.3	$ 1.0	$ 1.3

XML

Allowance for Doubtful Accounts - Notes Receivable Disaggregated by Vintage Year (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Current-period gross write-offs
2021			$ 0
2020			0
2019			0
2018			315
2017			2,493
Prior			0
Total			2,808
Current-period recoveries
2021			0
2020			0
2019			(1)
2018			0
2017			0
Prior			(37)
Total			(38)
Current-period net write-offs
2021			0
2020			0
2019			(1)
2018			315
2017			2,493
Prior			(37)
Total	$ 0	$ 253	2,770	$ 2,421
Standard notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2021	11,414		11,414
2020	8,181		8,181
2019	2,060		2,060
2018	18,980		18,980
2017	21,289		21,289
Prior	1,560		1,560
Total	63,484		63,484
Current-period net write-offs
Total	0	253	9	1,974
Elevated risk notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2021	0		0
2020	0		0
2019	617		617
2018	0		0
2017	723		723
Prior	1,374		1,374
Total	2,714		2,714
Current-period net write-offs
Total	$ 0	$ 0	$ 2,761	$ 447

XML

Allowance for Doubtful Accounts - Age Analysis of Past-Due Note Receivable (Details) $ in Thousands	Sep. 30, 2021 USD ($)
0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 5,709
91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	877
Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	8,303
Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	14,889
Standard notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	63,484
Standard notes receivable | 0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	5,709
Standard notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	877
Standard notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	5,589
Standard notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	12,175
Elevated risk notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	2,714
Elevated risk notes receivable | 0-90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0
Elevated risk notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0
Elevated risk notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	2,714
Elevated risk notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 2,714

XML

Allowance for Doubtful Accounts - Schedule of Changes in Allowance for Notes Receivable (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accounts receivable
Accounts receivable, Allowance for doubtful accounts, beginning balance	$ 50,243	$ 66,299	$ 51,052	$ 39,903
Write-Offs	(427)	(2,475)	(7,807)	(16,871)
Bad Debt Expense	4,230	967	10,801	5,050
Accounts receivable, Allowance for doubtful accounts, ending balance	54,046	64,791	54,046	64,791
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance	14,117	17,687	16,749	12,490
Write-Offs	0	(253)	(2,770)	(2,421)
Bad Debt Expense	(149)	(132)	(11)	1,706
Notes receivable, Allowance for doubtful accounts, ending balance	13,968	17,302	13,968	17,302
Total accounts and notes receivable
Allowance for doubtful accounts, beginning balance	64,360	83,986	67,801	52,393
Write-Offs	(427)	(2,728)	(10,577)	(19,292)
Bad Debt Expense	4,081	835	10,790	6,756
Allowance for doubtful accounts, ending balance	68,014	82,093	68,014	82,093
Accounts receivable recovered after write off		100	100	900
Cumulative effect of ASC 326 adoption
Accounts receivable
Accounts receivable, Allowance for doubtful accounts, beginning balance				36,709
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance				5,527
Total accounts and notes receivable
Allowance for doubtful accounts, beginning balance				42,236
Standard notes receivable
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance	12,534	11,869	13,258	6,667
Write-Offs	0	(253)	(9)	(1,974)
Bad Debt Expense	(149)	(132)	(864)	1,555
Notes receivable, Allowance for doubtful accounts, ending balance	12,385	11,484	12,385	11,484
Standard notes receivable | Cumulative effect of ASC 326 adoption
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance				5,236
Elevated risk notes receivable
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance	1,583	5,818	3,491	5,823
Write-Offs	0	0	(2,761)	(447)
Bad Debt Expense	0	0	853	151
Notes receivable, Allowance for doubtful accounts, ending balance	$ 1,583	$ 5,818	$ 1,583	5,818
Elevated risk notes receivable | Cumulative effect of ASC 326 adoption
Notes receivable
Notes receivable, Allowance for doubtful accounts, beginning balance				$ 291

XML

Changes in Accumulated Other Comprehensive Income by Component - Summary (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accumulated other comprehensive income
Beginning balance	$ 488,304	$ 449,687	$ 480,461	$ 460,305
Other comprehensive (loss) income before reclassifications			(1,421)	1,925
(Gains) losses reclassified from other comprehensive income			(161)	71
Net current period other comprehensive (loss) income			(1,582)	1,996
Ending balance	480,205	464,750	480,205	464,750
Realized gain			200
Realized loss				100
Changes in other comprehensive (loss) income, tax expense (benefit)			(400)	500
Accumulated Other Comprehensive Income, net of taxes
Accumulated other comprehensive income
Beginning balance	4,995	4,042	5,563	2,919
Ending balance	$ 3,981	$ 4,915	$ 3,981	$ 4,915

XML

Changes in Accumulated Other Comprehensive Income by Component - Reclassification Adjustments (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax (expense) benefit	$ (2,581)			$ (9,488)			$ (16,378)	$ (23,391)
Net income	9,540	$ 9,565	$ 24,653	27,644	$ 23,101	$ 20,190	43,758	70,935
Realized Gains (Losses) on Sale of Available-for-sale Securities | Amounts Reclassified from Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (losses) from the sale of available-for-sale securities	(7)			(7)			221	(94)
Tax (expense) benefit	5			2			(60)	23
Net income	$ (2)			$ (5)			$ 161	$ (71)

XML

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Operating lease — right-of-use assets	$ 32,032		$ 32,032		$ 26,074
Total property and equipment, at cost	52,180		52,180		47,532
Less accumulated depreciation	24,363		24,363		20,971
Total property and equipment, net	27,817		27,817		$ 26,561
Depreciation	2,500	$ 2,500	7,700	$ 7,600
ROU Assets depreciation	$ 1,600	$ 1,400	$ 4,700	$ 4,200
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Total property and equipment, net		Total property and equipment, net		Total property and equipment, net
Housekeeping and dietary equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 13,145		$ 13,145		$ 13,862
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,402		5,402		6,015
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,601		$ 1,601		$ 1,581

XML

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lessee, Lease, Description [Line Items]
Termination option			1 year
Reduction in ROU Assets due to cancellation	$ 0.3	$ 0.1	$ 0.6	$ 0.3
Reduction in Lease Liability due to cancellation	$ 0.3	$ 0.1	$ 0.6	$ 0.3
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year		1 year
Extension option	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	8 years		8 years
Extension option	5 years		5 years

XML

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Lease, Cost [Abstract]
Operating lease cost	$ 1,629	$ 1,404	$ 4,547	$ 4,153
Short-term lease cost	122	135	558	388
Variable lease cost	73	188	(458)	450
Total lease cost	$ 1,824	$ 1,727	4,647	4,991
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases			$ 4,902	$ 2,793
Weighted-average remaining lease term — operating leases	4 years 9 months 18 days	5 years 1 month 6 days	4 years 9 months 18 days	5 years 1 month 6 days
Weighted-average discount rate — operating leases	4.20%	4.90%	4.20%	4.90%

XML

Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Sep. 30, 2021 USD ($)
Leases [Abstract]
October 1 to December 31, 2021	$ 1,683
2022	6,131
2023	4,354
2024	2,225
2025	1,311
2026	1,337
Thereafter	2,867
Total minimum lease payments	19,908
Less: imputed lease discount	1,700
Present value of lease liabilities	$ 18,208

XML

Other Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Weighted average useful life			9 years 10 months 24 days
Amortization of intangible assets	$ 1.1	$ 1.0	$ 3.3	$ 3.1

XML

Other Intangible Assets - Estimated Amortization Expense For Intangibles Subject To Amortization (Details) $ in Thousands	Sep. 30, 2021 USD ($)
Intangible Assets, Net (Excluding Goodwill) [Abstract]
October 1 to December 31, 2021	$ 1,105
2022	4,416
2023	3,420
2024	2,286
2025	2,286
2026	2,270
Thereafter	$ 1,256

XML

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Unrealized (loss) gain on available-for-sale marketable securities, net of taxes	$ (1,014)	$ 703	$ (1,271)	$ 873	$ 1,656	$ (533)	$ (1,582)	$ 1,996
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds							12,368	5,979
Realized loss								(100)
Realized gain							200
Net unrealized gains related to equity securities	(100)			3,200			4,000	4,200
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds	300			200			12,400	6,000
Realized loss	$ (100)			$ (100)				$ (100)
Realized gain							$ 200

XML

Fair Value Measurements - Marketable Securities and Deferred Compensation Fund Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 125,583	$ 125,012
Deferred compensation fund	50,711	46,825
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	47,777	43,819
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,934	3,006
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	50,711	46,825
Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	50,711	46,825
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	125,583	125,012
Municipal bonds — available-for-sale | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	125,583	125,012
Municipal bonds — available-for-sale | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	125,583	125,012
Municipal bonds — available-for-sale | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	125,583	125,012
Money Market | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Money Market | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,934	3,006
Money Market | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Money Market | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,934	3,006
Money Market | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,934	3,006
Balanced and Lifestyle | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	11,922	10,815
Balanced and Lifestyle | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Balanced and Lifestyle | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Balanced and Lifestyle | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	11,922	10,815
Balanced and Lifestyle | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	11,922	10,815
Large Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	18,833	17,223
Large Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Large Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Large Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	18,833	17,223
Large Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	18,833	17,223
Small Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	6,010	5,337
Small Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Small Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Small Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	6,010	5,337
Small Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	6,010	5,337
Fixed Income | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	4,882	4,850
Fixed Income | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Fixed Income | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Fixed Income | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	4,882	4,850
Fixed Income | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	4,882	4,850
International | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,328	2,250
International | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
International | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
International | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,328	2,250
International | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,328	2,250
Mid Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	3,801	3,344
Mid Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Mid Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Mid Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	3,801	3,344
Mid Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 3,801	$ 3,344

XML

Fair Value Measurements - Marketable Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost		$ 120,543	$ 117,970
Gross Unrealized Gains		5,316	7,043
Gross Unrealized Losses		(276)	(1)
Estimated Fair Value		125,583	125,012
Other-than-temporary Impairments	$ 0	0
Municipal bonds — available-for-sale
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost		120,543	117,970
Gross Unrealized Gains		5,316	7,043
Gross Unrealized Losses		(276)	(1)
Estimated Fair Value		125,583	$ 125,012
Other-than-temporary Impairments	$ 0	$ 0

XML

Fair Value Measurements - Contractual Maturities of Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Maturing in one year or less	$ 6,207	$ 2,927
Maturing in second year through fifth year	32,788	26,324
Maturing in sixth year through tenth year	52,902	55,366
Maturing after ten years	33,686	40,395
Total debt securities	$ 125,583	$ 125,012

XML

Share-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	$ 6,968	$ 5,917
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	1,381	1,594
Restricted stock units and deferred stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	4,797	3,898
Performance stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	299	0
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	$ 491	$ 425

XML

Share-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions			9 Months Ended
	Jun. 04, 2021	Jan. 04, 2021	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant-date fair value of stock options granted (in dollars per share)			$ 7.01	$ 4.65
Aggregate intrinsic value of stock options exercised			$ 0.6	$ 0.9
SERP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)			1,000,000
Remaining shares authorized for issuance (in shares)			300,000
2020 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares)			4,900,000
Shares available for future grant (in shares)			2,000,000
Maximum term of grants			10 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 20.0
Period of expense of unrecognized compensation cost, years			2 years 10 months 24 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			262,000	300,000
Weighted average grant date fair value of stock granted (in dollars per share)			$ 28.53	$ 24.43
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			0	0
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 0.9
Period of expense of unrecognized compensation cost, years			2 years 4 months 24 days
Granted (in shares)		35,000	35,000
Weighted average grant date fair value of stock granted (in dollars per share)			$ 34.52
Vesting period			3 years
DSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 0.2
Period of expense of unrecognized compensation cost, years			8 months 12 days
Granted (in shares)	10,000
Vesting period	1 year
Payout period	5 years
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grant (in shares)			2,100,000
Average weekly hours of work			20 hours
Requisite service period for plan participation eligibility			2 years
Stock options authorized to issue to employees (in shares)			4,100,000

XML

Share-Based Compensation - Summary of Stock Options Outstanding (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2021 $ / shares shares
Number of Shares
Beginning of period (in shares) | shares	2,098
Granted (in shares) | shares	207
Exercised (in shares) | shares	(98)
Forfeited (in shares) | shares	(1)
Expired (in shares) | shares	(10)
End of period (in shares) | shares	2,196
Weighted Average Exercise Price
Beginning of period (in dollars per share) | $ / shares	$ 33.35
Granted (in dollars per share) | $ / shares	28.45
Exercised (in dollars per share) | $ / shares	22.93
Forfeited (in dollars per share) | $ / shares	39.38
Expired (in dollars per share) | $ / shares	33.64
End of period (in dollars per share) | $ / shares	$ 33.35

XML

Share-Based Compensation - Assumptions for Fair Value of Options Granted (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Risk-free interest rate	0.60%	1.80%
Weighted average expected life	6 years 7 months 6 days	6 years 7 months 6 days
Expected volatility	34.70%	26.60%
Dividend yield	2.90%	3.20%

XML

Share-Based Compensation - Summarized Information About Stock Awards (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares
Outstanding:
Aggregate intrinsic value	$ 900
Weighted average remaining contractual life	5 years 1 month 6 days
Exercisable:
Number of options (in shares) | shares	1,551
Weighted average exercise price (in dollars per share) | $ / shares	$ 33.32
Aggregate intrinsic value	$ 800
Weighted average remaining contractual life	4 years

XML

Share-Based Compensation - Summary of Restricted Stock Units (Details) - RSUs - $ / shares	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Number
Beginning balance (in shares)	561,000
Granted (in shares)	262,000	300,000
Vested (in shares)	(147,000)
Forfeited (in shares)	(12,000)
Ending balance (in shares)	664,000
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 33.31
Granted (in dollars per share)	28.53	$ 24.43
Vested (in dollars per share)	35.48
Forfeited (in dollars per share)	29.88
Ending balance (in dollars per share)	$ 31.01

XML

Share-Based Compensation - Summary of Outstanding Performance Stock Units (Details) - PSUs - $ / shares shares in Thousands		9 Months Ended
	Jan. 04, 2021	Sep. 30, 2021
Number
Beginning balance (in shares)		0
Granted (in shares)	35	35
Vested (in shares)		0
Forfeited (in shares)		0
Ending balance (in shares)		35
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)		$ 0
Weighted average grant date fair value of stock granted (in dollars per share)		34.52
Vested (in dollars per share)		0
Forfeited (in dollars per share)		0
Ending balance (in dollars per share)		$ 34.52

XML

Share-Based Compensation - Assumptions For Employee Stock Purchase Plan (Details)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.60%	1.80%
Weighted average expected life (years)	6 years 7 months 6 days	6 years 7 months 6 days
Expected volatility	34.70%	26.60%
Dividend yield	2.90%	3.20%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.10%	1.60%
Weighted average expected life (years)	1 year	1 year
Expected volatility	61.70%	42.00%
Dividend yield	2.90%	3.30%

XML

Share-Based Compensation - Deferred Compensation Plan (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	$ 6,968	$ 5,917
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	458	444
Unrealized gain recorded in SERP liability account	$ 3,990	$ 3,973

XML

Income Taxes (Details) $ in Millions	Sep. 30, 2021 USD ($)
Income Tax Disclosure [Abstract]
Impact of discrete tax items	$ 2.2
Unrecognized tax benefits	$ 0.0

XML

Segment Information - Schedule of Information of Reportable Segments (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($) segment	Sep. 30, 2020 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting Information [Line Items]
Revenues	$ 415,590	$ 435,947	$ 1,221,512	$ 1,337,126
Income before income taxes	12,121	37,132	60,136	94,326
Corporate and eliminations
Segment Reporting Information [Line Items]
Income before income taxes	(12,375)	(7,282)	(48,964)	(32,284)
Housekeeping
Segment Reporting Information [Line Items]
Revenues	203,379	223,423	621,278	675,366
Housekeeping | Operating segments
Segment Reporting Information [Line Items]
Income before income taxes	17,237	24,784	68,025	73,983
Dietary
Segment Reporting Information [Line Items]
Revenues	212,211	212,524	600,234	661,760
Dietary | Operating segments
Segment Reporting Information [Line Items]
Income before income taxes	$ 7,259	$ 19,630	$ 41,075	$ 52,627

XML

Earnings Per Common Share - Schedule of Weighted Average Basic and Diluted Common Shares (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator for basic and diluted earnings per share:
Net income	$ 9,540	$ 9,565	$ 24,653	$ 27,644	$ 23,101	$ 20,190	$ 43,758	$ 70,935
Denominator:
Weighted average number of common shares outstanding - basic (in shares)	74,943			74,700			74,983	74,684
Effect of dilutive securities (in shares)	133			77			187	84
Weighted average number of common shares outstanding - diluted (in shares)	75,076			74,777			75,170	74,768
Basic earnings per common share (in dollars per share)	$ 0.13			$ 0.37			$ 0.58	$ 0.95
Diluted earnings per common share (in dollars per share)	$ 0.13			$ 0.37			$ 0.58	$ 0.95

XML

Earnings Per Common Share - Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Anti-dilutive (in shares)	2,184	2,244	1,788	2,145

XML

Other Contingencies (Details) - USD ($)		3 Months Ended	9 Months Ended
	Sep. 15, 2021	Sep. 30, 2021	Sep. 30, 2021
Short-term Debt [Line Items]
Bank line of credit		$ 475,000,000	$ 475,000,000
Long-term Line of Credit		0	0
Reduction of bank line of credit			64,900,000
Amount available under line of credit		410,100,000	410,100,000
SEC
Short-term Debt [Line Items]
Civil monetary penalty		6,000,000
Shareholder class action
Short-term Debt [Line Items]
Settlement	$ 16,800,000
Irrevocable standby letters of credit
Short-term Debt [Line Items]
Irrevocable standby letter of credit, outstanding		$ 64,900,000	$ 64,900,000
LIBOR
Short-term Debt [Line Items]
Basis spread on variable rate			1.15%
Prime Rate or Overnight Bank Funding Rate
Short-term Debt [Line Items]
Basis spread on variable rate			0.50%

XML

Subsequent Events (Details) - Shareholder class action - USD ($) $ in Millions	Oct. 15, 2021	Sep. 15, 2021
Subsequent Event [Line Items]
Litigation settlement		$ 16.8
Subsequent Event
Subsequent Event [Line Items]
Litigation settlement	$ 16.8